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Reunion Chair John M. Fenlin Jr. 
'63 and Class Agent Phillip J. 
Marone 'S7 at the October 8 
Leadership Dinner, 
the kickoff for the 50th 
Annual Giving Campaign 
Upcoming Events 
January 8, Thursday, 4:00 P.M. 
The Rehfuss Lecture: Nobel laureate Gertrude Elion, D.Sc. 
will speak on "Challenges and Rewards of Pharmaceutical Research" 
Connelly Conference Hall, Bluemle Building 
January 21, Wednesday 
"Beef and Brew" to greet first yearstudents 
January 22, Thursday 
Alumni Executive Committee Meeting 
January 31—February 7 
Ski Meeting, Big Sky, Montana 
February 5, Thursday 
State of the University and Medical College 
Presentation at 5:00 P.M.—see page 31 
February 26, Thursday 
Alumni Executive Committee Meeting 
March I, Sunday 
Alumni Reception at the meeting of the American Academy of 
Dermatology, Orlando, Florida 
March 13, Friday 
Parents' Day for the sophomore class and their families 
March 20, Friday 
Alumni Reception at the meeting of the American Academy of 
Orthopaedic Surgeons, New Orleans 
April 3, Friday 
Alumni Reception at the meeting of the American College of 
Physicians, San Diego 
May 10, Sunday 
Alumni Reception at the meeting of the American College of 
Obstetricians and Gynecologists, New Orleans 
May 28, Thursday 
Commencement 
Class Agents Bret R. Sokoloff '96 
and Raj K. Sinha '89 
Agents for the Class of '58 
Peter Amadio Jr. and 
Herbert G. Hopwood Jr. 
May 31, Sunday 
Alumni Reception at the meeting of the American Psychiatric 
Association, Toronto 
June I, Monday 
Alumni Reception at the meeting of the American Urological 
Association, San Diego 
Reunion Weekend '98 
June 5, Friday, Alumni Banquet 
June 6, Saturday, Clinic Presentations, Reunion Parties 
June 7, Sunday, Farewell Brunch 
June 7-11 
Trip to Bermuda—see page 30 
John J. Gartland S'44 and 
Stacy L. Rollins Jr. J'44 
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50th YEAR of ANNUAL GIVING 
Annual Giving Celebrates a Half-Century of Strengthening Jefferson 
s Jefferson Medical College celebrates the 50th anniversary of its Alumni 
Annual Giving Campaign, a fund raising effort that has been recognized 
repeatedly as one of the finest institutional campaigns in the country, it 
seems timely to not only recall how this effort came into being, but also to 
record and celebrate its growth and significance for Jefferson. Money 
contributed in the Alumni Annual Giving Campaigns gives the Dean access 
to indispensable discretionary funds which allow him to take advantage of 
academic opportunities and to meet academic emergencies. 
This additional money allows the Dean to recruit and retain 
the best faculty, and to support research by young investi-
gators while they are competing for major National Institutes 
of Health grant funding. Annual Giving also provides 
additional student financial aid and emergency funds for 
students. Since 1988, contributors to Alumni Annual Giving 
have donated $2,425,443 to student financial aid. 
Annual Giving provides the Dean with over one million 
dollars in unrestricted funds. In describing the academic 
opportunities and academic emergencies for which these 
funds are needed, Dean Joseph S. Gonnella says "Some of 
these unanticipated situations include the programs of the 
Kimmel Cancer Center, support for the development of our pool of primary 
care physicians, the recruitment of department chairs and faculty, the 
remodeling of research space and the purchase of specialized equipment 
needs for researchers, support for the Alumni Professorship in Family 
Medicine, emergency funds for medical students and for providing 
specialized transportation needs for students to implement 
new curricular projects, the refurbishing of educational 
facilities, such as providing classroom audiovisual support 
and computer facilities, and support for students to work 
with faculty in the development of computer assisted 
materials." 
The original stimulus for Jefferson to initiate Alumni Annual 
Giving can be traced to Samuel D. Gross, Class of 1828. In a 
March 11, 1871 address to the fledgling Alumni Association 
of Jefferson Medical College on its first anniversary, Dr. 
Gross, Professor of Surgery and President of the newly 
formed Alumni Association said "Measures should be 
adopted to endow scholarships and professorships. Some of 
our alumni are men of large means and they could therefore well afford to 
aid in such a praiseworthy enterprise." Although a formalized yearly Annual 
Giving Campaign did not begin at Jefferson for an additional 77 years, 
Gross's challenge to the alumni of Jefferson Medical College immediately 
bore fruit. In 1872, a committee of the Alumni Association 
was appointed to secure funds to purchase a site on which to 
build Jefferson's first definitive hospital. During a time when 
a monetary panic was sweeping the country, this original 
alumni fund raising effort totalled just over $350,000. Five 
years later the hospital was ready for occupancy. It was one 
of the first hospitals in America to be part of a medical 
college for the teaching of clinical skills to medical students 
at the bedside. 
Following a few unsuccessful attempts at alumni fund raising 
prior to 1948, Gross's sage advice finally was acted upon in 
an organized fashion in 1948 with the launching of 
Jefferson's first Alumni Annual Giving Campaign under the 
chairmanship of Louis H. Clerf '12. Dr. Clerf is credited with envisioning a 
class agent system that would provide ongoing communication with the 
medical college through classmate/colleague direct mail solicitation. The 
first Alumni Annual Giving Campaign in 1948 raised $108,313 for Jefferson 
from 3060 contributors. Much of the success of this initial Jefferson fund 
raising effort was credited to the skill, imagination, hard work and personal 
generosity of the class agents representing each class. During this initial fund 
raising campaign the Alumni Association agreed that an award would be 
presented to the class raising the largest amount of money, to the class with 
the highest percent participation and to the class with the highest number of 
contributors. The class agent system has proven to be a very successful 
device and has remained the core strength of Jefferson's 
Alumni Annual Giving effort. 
Louis H. Clerf '12 served as Chairman of the Alumni Annual 
Giving Program from 1948 to 1951. He was followed as 
Chairman by Theodore R. Fetter '26 who served from 1952 to 
1955. Next came John H. Gibbon Jr. '27 who served from 1956 
to 1959. He was followed by Carroll R. Mullen '26 (1960-1961) 
and Kenneth E. Fry '31 (1961-1964). J. Wallace Davis '42 
became Chairman of the Alumni Annual Giving Campaign 
Committee in 1965 and has led this effort since as the longest 
serving Chairman. He has proven to be an innovative and 
successful leader, instituting initiatives such as the President's 
Club and other categories for giving such as the Nongraduate 
Faculty and the Postgraduate Alumni. His efforts on behalf of Annual Giving 
and the Alumni Association were recognized at the President's Club Dinner 
in 1978 when he was presented with the Board of Trustees prestigious 
Cornerstone Award. He received Jefferson Medical College's Alumni 
Achievement Award in 1991. 
Alumni Annual Giving surpassed $1,000,000 for the first time 
during the 1983 Campaign. The total amount raised during the 
recently completed 49th Campaign was an all-time high of 
$1,761,935 from 4000 contributors. The goal for the 50th 
Campaign is to surpass $2,000,000. From its inception in 1948 
to the present, loyal Jeffersonians have contributed a grand 
total of $31,235,758 for the medical college and its programs. 
This magnificent expression of loyalty and support for the 
medical college and its programs by the Alumni Association 
was recognized by the Thomas Jefferson University Board of 
Trustees who, at the President's Club dinner on October 3, 
1997, presented their Cornerstone Award to the Alumni 
Association of Jefferson Medical College. Over the years 
Jefferson's Alumni Annual Giving Campaign has been recognized as one of 
the finest institutional fund raising efforts in the country. The American 
Alumni Council in 1962 awarded a trophy, together with a check for $1000 
from the United States Steel Foundation, to Jefferson for placing first among 
Professional Schools for outstanding sustained performance in 
Annual Giving. Jefferson won the award again in 1965, and 
again in 1970. Jefferson's Alumni Annual Giving record of 
achievement also was a positive factor in helping the Alumni 
Association win a national prize from the Association of 
American Medical Colleges in 1995 during the 125th 
Anniversary Celebration of the founding of the Alumni 
Association of Jefferson Medical College. The AAMC's Award 
for Excellence in Public Affairs was presented to Jefferson for 
this multifaceted celebration of the history and the future of 
Jefferson Medical College. 
The President's Club, established in 1971, grants membership 
to alumni and others who contribute gifts of $1,000 or more. 
Benjamin Bacharach '56, Clinical Professor of Surgery, Vice-Chairman of the 
Department and Associate Dean for Admissions has chaired the President's 
Club Committee since 1977. In addition, he has chaired the Student 
Financial Aid Drive since 1988 which, at this writing, totals $2,425,443. 
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Dr. Mullen 
Dr. Fry 
Drs. Bacharach and Davis 
In the 49th Campaign, 587 members of the President's Club contributed 
$1,132,253 or 64.2 percent of the total amount raised in that Campaign. 
Other categories for giving established since 1948 are the Nongraduate 
Faculty and the Postgraduate Alumni. In the 49th Campaign these two 
groups combined to contribute $246,461. Although not a part of Alumni 
Annual Giving, the University maintains a Development Office to work with 
large contributors in developing charitable trusts, bequests for 
buildings or endowed professorships. Under certain circum-
stances, alumni who give large gifts through the Development 
Office may have their gifts credited to their class. 
In his address to the fledgling Alumni Association in 1871, 
Dr. Samuel Gross pointed out that "measures should be 
adopted to endow scholarships and professorships." He 
would be pleased to know his request has been answered in 
abundance. In 1973 the Alumni Association established the 
Alumni Professorship of Family Medicine with a pledge of 
continuing support. Dale W. Garber '24 established the Ellen 
M. and Dale W. Garber Professorship of Family Medicine in 
1984. Vernon Watson Pugh '53 established the Dr. Vernon 
Watson Pugh and Frances Plimpton Pugh Professorship of Microbiology and 
Immunology in 1985. Bernard W. Godwin Jr. '55 established the Bernard J. 
Godwin Jr. Professorship in Prostate Cancer Research in 1989. Also in 1989, 
Warren R. Lang '43 established the Warren R. Lang Professorship of 
Pathology. Everett J. Gordon '37 established the Dr. Everett J. and Marian 
Gordon Professorship in Orthopaedic Surgery in 1991, and in 
1995 Paul A. Bowers '37 established the Paul A. and Eloise B. 
Bowers Professorship of Obstetrics and Gynecology. Robert L. 
Brent, M.D., Ph.D. and Lillian Brent established the Brent 
Professorship of Pediatrics in 1996. 
Friends of Jefferson Medical College have been equally 
supportive. In 1910, Maria Gross Horwitz, daughter of 
Samuel D. Gross of the Class of 1828, established the Samuel 
D. Gross Professorship of Surgery. In 1946, Henry Reed 
Hatfield, son of Nathan Lewis Hatfield of the Class of 1826, 
established the Nathan Lewis Hatfield Professorship of 
Urology. Beatrice Wilson, daughter of James C. Wilson of the 
Class of 1869, established the James C. Wilson Professorship 
of Medicine in 1973. In 1992, Dorrance H.(Mrs. Samuel M. V.) Hamilton, a 
term Trustee of the Board of Trustees of Thomas Jefferson University, 
established the Dorrance H. Hamilton Professorship of Medicine, and the 
Samuel M. V. Hamilton Family Professorship of Medicine. In addition, 
alumni friendships with community leaders frequently result in unexpected 
funding sources. An alumnus introduced his 
friend, Sidney Kimmel, to Jefferson Medical College 
a few years back. Sidney Kimmel, Chairman and 
CEO of Jones Apparel Group, is very much involved 
with philanthropy through the Sidney Kimmel 
Foundation. In 1991, he donated funds to Jefferson 
Medical College to establish the Kimmel Cancer 
Center which now has achieved designation as a 
Clinical Cancer Center by the National Cancer 
Institute. 
Much of Jefferson's success in Alumni Annual Giving 
can be credited to how the effort has been 
structured. From the beginning, each alumni class 
has been solicited individually by a class agent, a classmate chosen specifi-
cally for this role. Class agents write the multiple solicitation letters sent to 
their classmates during each campaign, make telephone calls and otherwise 
encourage their classmates to contribute. These efforts are in addition to the 
efforts made by the Chairman and members of the Annual Giving Fund 
Committee. The class agent effort has been coordinated successfully for 
many years by Joan E. Schott in the Alumni Office. Class agents send their 
newly written class letters to Joan Schott who then has them individualized 
by an outside secretarial service. They are returned then to each class agent 
for personal signature and mailing. The class agent strategy stimulates class 
loyalty and engenders friendly competition among and between the classes. 
During the recently completed 49th Campaign, nine classes 
reached or exceeded a class participation rate of 50 percent. 
Mary Monteith, executive director of the Jefferson Medical 
College Alumni Association, says "The class agents are the 
real backbone of Annual Giving. Jefferson's continuing 
success in Alumni Annual Giving largely is due to their 
interest, their loyalty, and their hard work. Our class agent 
system is the envy of many medical schools." 
At the completion of the 49th Campaign, the Class of 1971 
led by class agents James E. Barone and Terrence S. Carden Jr. 
raised $48,237 to win the prize for the amount raised. The 
Class of 1968, led by Lawrence V. Hofmann and Harold A. 
Yocum, was second with $45,680, and the Class of 1969, led 
by M. Dean Kinsey, took third with $42,030. The Class of 1978, led by class 
agent Duncan Salmon, took top honors in the number of contributors 
category with 103 classmates making a gift to Annual Giving. The Class of 
1971, led by class agents James E. Barone and Terrence S. Carden Jr. took 
second place with 89 contributors, followed by the Class of 1984, led by 
class agent Guy M. Stofman, with 88 contributors. The Class 
of 1947, celebrating its 50th reunion and led by class agent 
Martin M. Mandel, checked in with an amazing participation 
rate of 70 percent to win the top award in the participation 
category. The Class of 1954, led by class agent John R. 
Patterson, was second with a participation rate of 68 percent. 
The 40th reunion Class of 1957, led by class agents Phillip.). 
Marone and Bronson J. McNierney finished third with a 
participation rate of 65.2 percent. Other frequent award 
winners over the years have been the Class of 1946, led by 
class agent James V. Mackell, and the Class of 1956, led by 
class agent Eugene F. Bonacci. In addition, to celebrate its 
35th reunion in 1991, the Class of 1956 donated a large 
commemorative clock which is displayed now on the west 
wall of Scott Plaza. The Nongraduate Faculty, led by Robert L. Brent, The 
Distinguished Professor and the Louis and Bess Stein Professor Emeritus of 
Pediatrics, contributed $163,312. The Postgraduate Alumni, led by Francis 
X. Keeley, IM'60 and Lorraine C. King, REN'77, contributed $83,149. 
Jefferson approaches the 50th Alumni Annual 
Giving Campaign pleased with the growth of the 
program since 1948, but not complacent about its 
results. The Alumni Association approaches the 50th 
Campaign with confidence built by a half century of 
experience, and with the expectation that the two 
million dollar goal will not only be reached, but also 
that it will be surpassed. This confidence is bolstered 
by the conviction that the alumni of Jefferson 
Medical College believe strongly in the support of 
private medical education. J. Wallace Davis '42, 
present Chairman of the Annual Giving Fund 
Committee, best expressed the belief of the Alumni 
Association about Jefferson Medical College alumni 
and Annual Giving when he wrote "I never cease to be impressed by the 
loyalty and generosity of Jefferson's alumni, faculty and friends." If Samuel 
D. Gross, Class of 1828 and the first president of the Alumni Association of 
Jefferson Medical College, could see what has resulted from his prxthetic 
exhortation of 1871, it is certain he would be extremely gratified. M 
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Raymond C. Grandon '45 
and Dr. and Mrs. J. Woodrow 
Savacool '38 
Dr. and Mrs. Edward H. McGehee '45 
on the dance floor 
YEAR o ANNUAL GIVING 
University Presents Cornerstone Award to the Alumni Association 
r I 'he Alumni Association of Jefferson Medical 
1 College was the recipient of the university's 
Cornerstone Award at the President's Club 
Dinner held in the landmark Crystal Tea Room 
at the Wanamaker Building. 
Jack Farber, Chairman of the Board of Trustees, 
presented the Alumni Association with the 
award for its "steadfast and enthusiastic" 
support of Jefferson for a half-century. The 
association, the largest group of living alumni of 
any medical school in the nation, has donated 
more than one million dollars to its alma mater 
for 14 consecutive years, and more than 
$31 million in total since its formation. 
University President Paul C. Brucker, M.D. also 
announced at the dinner that J. Wallace Davis 
'42, the longtime Chairman of Annual Giving, 
and his wife Gail have established a new trust to 
benefit Jefferson Medical College. Dr. Brucker 
said that the Davises' "outstanding generosity 
and commitment to Jefferson continue to 
astonish and encourage all of us." 
 
Proudly holding the Cornerstone Award is Alumni President Joseph W. 
Sokolowski Jr. '62, with Annual Giving Chairman J. Wallace Davis '42 
and immediate past Alumni President Stanton N. Smullens '61 
r 	 • 	 \4 
ft.,11(-74 1  I 
; 	 4111 
Dancing in the elegant 
Crystal Tea Room 
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Dr. and Mrs. 
James I. Kelly '39 
Annual Giving Chairman Dr. Davis (center) with Alumni Presidents (back row) Vernick, Poole, 
Funk, Sokolowski, Smullens, Bacharach, (front row) Gartland, Wagner, Baltzell, McGehee 
Mrs. Samuel M.V. Hamilton, 
Mr. and Mrs. Joseph Field, Dr. and Mrs. Stanton N. 	 Chairman of the Jefferson 2000 
Smullens '61, and Stephen L. Schwartz, M.D. 	 Campaign, with John M. Levinson '53 
and President Brucker 
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Screening for Breast Cancer 
Gerald D. Dodd '47 
he past five years have been confusing ones for women and 
physicians regarding recommendations for breast cancer 
screening in the United States. In 1989, the American Cancer 
Society (ACS), the National Cancer Institute (NCI), and 10 
other national organizations had established consensus 
guidelines on breast cancer screening. These included specific 
recommendations for the screening of asymptomatic women: 
mammography every one to two years for women ages 40 to 49, 
and annually for those 50 and older. The American College of 
Physicians, the American Academy of Family Practice, and the 
U.S. Preventive Services Task Force declined to endorse the 
guidelines, concluding that the available evidence was insuffi-
cient to support a recommendation for screening in the younger 
group. Nevertheless, the consensus was widely accepted and it 
seemed possible to proceed with the nationwide screening of 
women over 40. 
In late 1992, the preliminary results of the Canadian National 
Breast Screening Study were leaked. These showed no benefit at 
seven years of follow-up for the study groups who were offered 
screening mammography. In fact, the 40- to 49-year-old 
screened group had a higher mortality rate than the controls, a 
finding which received extensive press coverage. Although this 
amount was not statistically significant, both the NCI and the 
ACS initiated a review of their guidelines. 
In February 1993, separate meetings were held to analyze the 
new and existing data, particularly with regard to women ages 
40 to 49. Whereas the ACS concluded that there was insufficient 
new data to change the consensus guidelines, the NCI's 
International Workshop on Screening for Breast Cancer laid the 
groundwork for the NCI's unilateral withdrawal of support in 
September 1993. It is of interest that this action was taken 
despite a National Cancer Advisory Board (NCAB) vote of 14 to 
one against withdrawal. 
Between 1993 and 1996, several updated results were presented 
or published from the eight randomized controlled trials (RCTs) 
that included women 40 to 49 years of age. These data 
prompted both the NCI and the ACS to once again re-examine 
the question of screening younger women. A consensus 
conference was held in January 1997 under the auspices of the 
NIH, but with guidance from the same individuals who had 
Dr. Dodd, past national President of both the American Cancer 
Society and the American College of Radiology, is the Singleton 
Professor of Radiology at St. Luke's Episcopal Hospital, 
Houston, and from 1966 to 1992 was Head of the Division of 
Diagnostic Imaging at the University of Texas M. D. Anderson 
Cancer Center. M. D. Anderson inaugurated an endowed chair 
in his name, and in November presented a symposium on 
"New Directions in GI and Breast Imaging" in his honor. 
organized the 1993 NCI international workshop. Again, after 
two and one-half days of sometimes acrimonious debate, the 
consensus panel reached a preliminary conclusion that the 
newer information did not have sufficient impact to warrant a 
recommendation for the screening of those 40 to 49 years of 
age. 
The ACS meeting followed in February and reached an opposite 
conclusion. Not only did the ACS feel that screening of younger 
women was appropriate, but due to information regarding 
growth rates and sojourn time (time from when tumor is first 
evident radiogically to time when clinically palpable) in this age 
group, the ACS recommended that screening be carried out at 
annual intervals beginning at age 40. 
These conflicting positions added to the confusion that had 
followed the 1993 international workshop and led to 
Congressional hearings. The Director of the NCI stated that he 
was "shocked" by 
the panel's 
statement and 	 Seemingly overlooked 
referred the 	 in the academic dispute question to the 
NCAB for guidance is the fact that there are 
and advice. The 	 18 million women age N CAB 
subsequently voted 40 to 49, 33,400 of 
17 to one in favor 	 whom will develop 
of screening those 
40 to 49 years of 	 breast cancer each year. 
age, a recommen- 	 The solution must not dation which was 
promptly accepted depend entirely upon 
by the NCI. In 	 inexact statistical April 1997, the 
NCI issued a 	 methods. 
formal statement 
advocating the examination of women in their forties at one- to 
two-year intervals, a position which the ACS had abandoned in 
February. 
The consensus conference panel has refused to budge from its 
position and its final report states that there is insufficient 
evidence to warrant screening of younger women. It should be 
noted, however, that not all of the panel were in agreement and 
a minority report favoring screening of this group is also being 
published. Dr. Suzanne Fletcher, Chairman of the NCI's 1993 
International Workshop on Screening for Breast Cancer, has 
publicly commented in reference to the conflicting positions 
that major health care decisions are increasingly being made for 
political reasons and that scientific evidence has become 
secondary to other interests. 
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Seemingly overlooked in this academic dispute is the fact that 
there are 18 million women age 40 to 49, of whom 33,400 will 
develop breast cancer each year. This is a significant problem 
whose solution cannot depend entirely upon inexact statistical 
methods and RCTs performed with outdated technology. A 
pragmatic approach to all of the evidence for and against 
screening is warranted. 
RISKS AND COSTS 
A number of risks have been attributed to mammography, 
particularly with respect to the younger age group. These 
include discomfort and possible trauma from compression of 
the breast, and 
increased false-
positive and 
false-negative rates 
in younger women 
due to the 
radiographic density of premenopausal breasts. But few tests 
are performed without transient discomfort, and properly 
performed mammography does not traumatize the breast. 
Varying degrees of anxiety are experienced by most 
individuals facing medical tests and their outcome; they are 
not peculiar to mammography and certainly do not offer a 
valid reason for not recommending the examination. 
Considerations that are pertinent are radiation exposure and 
costs of the examination. 
Although there is no doubt that high doses of ionizing 
radiation have a carcinogenic potential, at clinical diagnostic 
levels this assumption is theoretical and obtained by extrapo-
lation from higher values. Using the data developed by the 
National Academy of Science on the biological effects of 
ionizing radiation, 150 radiogenic carcinomas can theoreti-
cally be anticipated per one million women who undergo 
annual screening mammography between the ages of 40 and 
75 years. During the same period, 93,000 spontaneous cancers 
will occur. This is a ratio of 650 to one. Since mammography 
is capable of imaging the majority of breast cancers, including 
those of radiogenic origin, the risk, when compared with the 
potential benefits of early diagnosis, is minimal. 
Assuming that annual mammographic screening is elected by 
70 percent of women age 40 to 49 at the present Medicare 
reimbursement rate of 55 dollars, the cost per annum comes 
to approximately 700 million dollars. This will be increased to 
a variable degree by supplemental diagnostic procedures. 
Overall, mammography has a true-positive rate of 85 to 90 
percent and, if confined to those in the 40- to 49-year age 
group, sensitivity decreases slightly. However, with experi- 
enced mammographers the difference is minimal and, with 
those of average experience, between 75 and 80 percent of 
cancers in young women will be detected. 
In this regard, it should be noted that there has been a signif-
icant improvement in the training of technologists and 
radiologists in the performance and interpretation of 
mammograms. Formal examination in the subspecialty is now 
required by the American Board of Radiology, and Congress has 
mandated strict quality control via the Mammography Quality 
Assurance Act of 1992. 
Of greater concern are the costs resulting from false-positive or 
indeterminant interpretations that require tissue biopsy to 
exclude cancer. The costs of open biopsy are high (three to five 
thousand dollars), but stereotactic core biopsies or ultrasoni-
cally guided fine-needle cytologic studies have the potential of 
replacing the majority of open biopsies at approximately one-
third the cost. Moreover, the bulk of initially questionable 
studies are resolved by supplementary imaging techniques; the 
rate of biopsy following mammography can be anticipated as 
about one to two percent when the mammographers are experi-
enced. 
BENEFIT ESTIMATES 
The major objection to the routine screening of women 40 to 49 
years of age centers about the supposedly marginal evidence of 
benefits derived from RCTs. Many factors enter into their design 
and evaluation. The various types of bias are well known and 
have been controlled to some extent in the screening studies. 
However, with the exception of the Canadian National Breast 
Screening Study (CNBSS), none of the trials has been specifi-
cally designed to detect the effectiveness of mammography in 
women 40 to 49 years of age. In each the number of women in 
this age group equalled one-third or less of the total study 
cohort; the effect of screening on a particular age group was 
determined by retrospective stratification. 
Considerable variability also occurred in the equipment 
employed, quality control procedures, the type and number of 
mammographic projections, and the interpretive experience of 
the radiologists. 
And the follow-up periods on the study populations also 
differed markedly, a factor of great importance in younger 
women. The original Health Insurance Plan of New York 
A Continuing Dilemma 
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screening trial showed no benefit to women 40 to 49 years of 
age at the end of five years, but at eight years the survival rate of 
the study group began to diverge from that of the controls. At 
10 years a 23 percent decrease in mortality could be 
demonstrated and this has remained relatively constant through 
the ensuing 10 years. 
Recognition of the limited statistical power in individual RCT, 
especially among women ages 40 to 49 years, has led some 
investigators to perform meta-analyses of the results of these 
trials. Meta-analyses combine the results from different studies, 
thereby increasing the total number of deaths and women-years 
(the number of women times the number of years of follow-up) 
in the collective study and control groups. Meta-analyses, 
however, are not panaceas. They provide a mathematical 
methodology for combining similar data (e.g., mortality data) 
from different trials, but are blind to potential differences in 
design, conduct, quality, and completeness of data among the 
studies. 
The evaluation of an individual RCT benefits from more 
complete follow-up data that covers a longer duration, and the 
same is true of a 
meta-analysis. An 
analysis presented 
by Elwood et al. at 
the 1993 interna-
tional workshop 
found no signif-
icant benefit from 
screening 
mammography in 
younger women, 
and was used as a 
reference point by 
the NCI when it 
withdrew its 
recommendation 
for routine 
screening for this group in 1993. However, only those data from 
seven years of follow-up were used, despite the fact that 
additional years were available. 
The Canadian trial, although well-structured in many respects, 
has been subjected to a number of criticisms. The relative merits 
of these can be debated, but the most pertinent appears to be 
the randomization process. Exactly what occurred is not clear, 
but an excess of advanced cases was assigned to the study 
group. Although this imbalance may be resolved with time, the 
initial relative risk of 1.36 percent significantly affects the 
results of a meta-analysis. 
Also worthy of note is the quality of mammography through at 
least half the Canadian trial. This was judged substandard by 
outside observers during the first two and one-half to three 
years, and average during the last two years of the trial. 
In 1995, Hendrick et al. performed a meta-analysis using more 
current evidence. The analysis showed a 14 percent decrease in 
mortality if the Canadian study was included. This number is 
not statistically significant; however, if the CNBSS is excluded 
there is a 24 percent decrease—a highly significant statistical 
figure. 
In 1997, a meta-analysis by the same investigators showed an 18 
percent decrease in mortality when the Canadian study was 
included. This number is statistically significant. The 
incremental differences between 1993 and 1997 indicate the 
importance of long-term follow-up when calculating benefits in 
younger women. 
The new data from two of the five Swedish trials, Gothenburg 
and Malmo, demonstrated for the first time statistically signif-
icant benefits from individual trials for the subgroup of women 
under age 50 at entry. The Gothenburg trial demonstrated a 44 
percent mortality reduction among women 39 to 49, and the 
Malmo trial a 36 percent reduction among women 45 to 49. All 
five Swedish trials, when considered as a group, yield a 29 
percent mortality reduction. All are statistically significant at the 
95 and 99 percent confidence levels. Inexplicably, these data 
were not included 
of the preliminary 
statement issued 
by the NCI's 
consensus 
conference panel 
in January 1997. 
Non-randomized 
trials and clinical 
series do not carry 
the same weight as 
randomized trials, 
but they do offer 
an indication of 
the potential worth 
of a procedure or 
concept. Data 
derived from the Breast Cancer Detection Demonstration Project 
(BCDDP), which involved the largest group of women in any 
study to date (283,322), indicated that the 20-year case distribu-
tions for the prognostic indicators most likely to be affected by 
early detection, are the same for all age groups. These include in 
situ neoplasms, invasive cancers without lymph node 
The Swedish trials, 
considered as a group, 
yield a 29 percent 
mortality reduction. 
Inexplicably, these data 
were not included in the 
preliminary statement 
issued by the NCI's 
consensus conference 
panel in January 1997. 
The recommendations 
by the American 
College of Physicians, 
the American Academy 
of Family Practice, and 
the Preventive Services 
Task Force will have a 
significant impact upon 
acceptance of the 
guidelines. 
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involvement, and lesions less than two cm in diameter (stages 
zero and one). The overall death rates and adjusted survival 
rates in these groups are essentially identical. Given the 
established benefit of mammography among women over age 
50, the similarity in survival and mortality pattern in all BCDDP 
age groups provides indirect evidence of the potential benefit of 
mammographic screening of women age 40 to 49. 
The BCDDP data was presented at both the 1993 and 1997 NCI-
NIH conferences. It was, however, essentially ignored in the 
conclusions reached by the panels. Also overlooked was the 
work of Tabar and his associates in Sweden who demonstrated 
that there was no significant difference in survival rates between 
the younger and older age groups provided that the diagnosis 
was made before a given tumor had exceeded 10 to 15 mm in 
diameter. These observations support the survival rates found in 
the BCDDP and indicate that screening at more frequent 
intervals may be necessary in younger women if maximum 
benefit is to be achieved. 
EFFECTIVENESS OF SCREENING 
To be effective a screening procedure should, over an 
appropriate period of time, show: 
1) an absolute increase in the number of early cases.  
2) an absolute 
decrease in the 
number of 
advanced cases, and 
3) an absolute 
decrease in 
mortality. 
Indications that 
these criteria are 
being met by 
mammography 
screening may be 
found in data 
gathered by the American College of Surgeons National Cancer 
Data Bank (NCDB) and in recent statistics compiled by the 
Surveillance, Epidemiology, and End Results (SEER) Program of 
the NCI. 
Between 1972 and 1988 the number of in situ cases reported to 
the NCDB rose from 1.9 to 12.9 percent. During the same 
period, regional cancers dropped from 42 to 27.8 percent, and 
patients with distant metastases decreased from 6.8 to 4.4 
percent. Correspondingly, the number of patients treated by 
partial mastectomy and radiation rose from three percent to 34 
percent, and the use of radical mastectomy declined from 50.4 
percent to two percent. 
Recent SEER figures shoW that the mortality rate of breast 
cancer, which had remained essentially unchanged since 1950, 
now shows a decline of 6.3 percent. This decrease is apparent in 
all age groups, varying from 9.3 percent in women 50 to 59 
years of age to 3.4 percent in those 70 to 79. Pertinent to this 
discussion is an 8.1 percent decrease in women 40 to 49 years of 
age. Undoubtedly adjuvant therapy played a part in this decline, 
but it is probable that the major factor is the detection of earlier 
stage disease due to the increasing use of mammography. A poll 
conducted by the Jacobs Institute in 1993 indicated that 74 
percent of women over 40 years of age have had at least one 
mammogram during adulthood. 
Given these results, it does not appear unwarranted to conclude 
that the effectiveness of screening, including women in the 40 
to 49 year age group, is now becoming apparent. It is also 
probable that the delayed appearance of benefit in younger 
women can be expected to result in a continuing decline in the 
mortality rate. However, as noted, not all agree with these 
conclusions. 
As of this date, the American College of Physicians, the 
American Academy of Family Practice, and the Preventive 
Services Task Force have not changed their positions. 
Obviously, their recommendations to their membership will 
have a significant impact upon acceptance of the present 
guidelines. Judging by Dr. Fletcher's recent statement, 
continued opposition can be expected in other quarters and a 
group of NCI staffers remain unconvinced that the statistics 
support the recommendation to screen younger women. 
In the face of these continuing disagreements, what should be 
the stance of practicing physicians? The annual rate of 34,000 
new cancers in women 40 to 49 is too large to be neglected. Be 
that as it may, only about half of women in all age groups follow 
the guidelines promulgated prior to 1997. The reasons for this 
vary greatly, but the outstanding factor is physician recommen-
dation. Many women are reluctant to initiate this practice on 
their own; their doctor must recommend it at appropriate 
intervals. There is also the matter of cost, and strenuous efforts 
are being made to require insurance coverage for screening 
procedures. 
Although mammography is somewhat less effective in the dense 
breasts of younger women, this is less of a barrier than generally 
indicated in the lay press. There is no question that subclinical 
cancers can be detected. One of only three screening techniques 
capable of diagnosing cancers in the preclinical state, mammog-
raphy has had a demonstrable effect on treatment patterns and 
survival rates. Cost-benefit ratios notwithstanding, the human 
element must be considered. It is prudent to screen all women 
over 40 until a superior detection method becomes available. '13 
Only about half of 
women follow the 
guidelines promulgated 
prior to 1997. The 
outstanding factor 
behind this is physician 
recommendation. 
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, , University Celebrates a Link to its Past: the McClellan House 
ecent research by Dan 
IN.-Flanagan, Archives 
Technician, Thomas Jefferson 
University, and Frederick B. 
Wagner Jr. '41, The Grace 
Revere Osler Professor 
Emeritus of Surgery and 
University Historian, 
unearthed the fact that 
Jefferson's founder, Dr. George 
McClellan, lived at 912 Walnut 
Street from 1832 until his 
death in 1847. His son, 
General George B. McClellan, 
also lived there until 1842 
when he left to attend West 
Point. Elizabeth Brinton 
McClellan, Dr. McClellan's 
widow, sold the home in 1853, 
but the McClellan-Jefferson 
connection continued. 
Between 1853 and 1913, two 
McClellans graduated from 
Jefferson, and the founder's 
grandson filled the chair of 
Applied and Topographical 
Anatomy from 1905 to 1913. 
The founder's brother, Dr. 
Samuel McClellan 
(1800-1854), was a faculty 
member and served as Dean 
from 1830 to 1834. Samuel's 
father-in-law, Reverend Ezra 
Stiles Ely, was a member of the 
original Board of Trustees and 
Jefferson's first major 
benefactor. 
No pertinent information can 
be found about 912 Walnut 
Street between 1853 and the 
turn of the century. However, 
the Alumni Bulletin of October 
1956 pays tribute to a local 
institution which loomed large 
in the hearts of many Jefferson 
students and faculty. The 
article states, "Almost as much 
a part of Jefferson as its labora-
tories and classrooms, is a 
small barber shop at 912 
Walnut Street, presided over 
by J. Monroe Dean. Mr. Dean 
has been friend and 
confidante, as well as barber, 
to many of Jefferson's 'greats,' 
and has been serving Jefferson 
men since he began his 
business in 1910." 
Unfortunately, because the 
connection between 912 
Walnut Street and the 
McClellan family was 
unknown at the time, the 
house at 912 Walnut Street was 
demolished in 1974 to make 
way for Barringer Residence 
Hall. 
The archival research proving 
the connection between 912 
Walnut Street and Jefferson 
was sufficient to persuade the 
Pennsylvania Historical and 
Museum Commission to allow 
the preparation of a curb site 
marker to signify the 
importance of the place. A 
dedication and unveiling 
ceremony, moderated by John 
J. Gartland S'44, was held 
October 14 in Connelly Hall 
of the Bluemle Building. The 
Reverend Edward C. Bradley, 
S.J., M.D.'55 opened the 
program with an invocation. 
The story behind the marker 
was told by Dan Flanagan and 
Frederick B. Wagner '41, and 
the Pennsylvania Historical and 
Museum Commission was 
thanked for making the 
celebration possible. 
The high point of the 
ceremony was the attendance 
of Mr. George Ely McClellan, 
second great-grand-nephew of 
Dr. George McClellan, and his 
family who came from Lacey's 
Spring, Alabama for the 
ceremony. Mr. McClellan 
presented the university with 
two rare medical books that 
came from the library of the 
founder, Dr. George McClellan, 
and were inscribed by him. The 
attendees applauded as Mr. 
McClellan unveiled the marker 
which stands at 912 Walnut 
Street as a perpetual reminder 
of the bond between Dr. 
George McClellan and 
Jefferson Medical College. 
1n December 1956 the Jefferson Medical College Alumni Bulletin 
paid tribute to a local institution 
which loomed large in the hearts of 
many students and faculty members: 
Almost as much a part of Jefferson 
as its laboratories and classrooms, 
is a small barber shop at 912 
Walnut Street, presided over by J. 
Monroe Dean. Mr. Dean has been 
friend and confidante, as well as 
barber, to many of Jefferson's 
"greats," and has been serving 
Jefferson men since he began his 
business in 1910. 
The names of Dean's clientele form 
a veritable who's who in the history 
of Jefferson Medical College. John 
Chalmers DaCosta '1885, John H. 
Gibbon Jr. '27, and J. Woodrow 
Savacool '38 are only a few of the 
names on record as having 
patronized this establishment. 
According to the article the 
barbershop provided a sanctuary for 
many overworked Jeffersonians: 
In Mr. Dean's shop students have 
poured out their troubles. Busy, 
tired, and harassed doctors have 
relaxed and, for a short time, 
forgotten the pressures of duties. 
Unbeknown to Mr. Dean and his 
customers, Jefferson students and 
faculty members were paying visits 
to this building long before the shop 
opened in 1910. By a strange coinci-
dence, the barber shop was situated 
in the basement of a house that once 
belonged to Dr. George McClellan, 
the founder of Jefferson Medical 
College. Dr. McClellan purchased 
the house in 1832 and occupied it 
until his death, which occurred on 
the premises in 1847. 
Dr. McClellan inspired fierce loyalty 
and devotion among the students, 
Dr. Gartland, Dr. Wagner, and Mr. McClellan 
in front of the newly placed sign 
912 Walnut Street: Last Residence 
of George McClellan, M.D., 
Founder of Jefferson Medical College 
Dan Flanagan, Archives Technician, Thomas Jefferson University 
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912 Walnut Street as it appeared ca. 1960. 
Note the barber pole at lower left. 
many of whom supplemented their 
education by obtaining McClellan's 
private instruction. McClellan 
routinely carried out their training in 
his home medical office. Though 
McClellan often exhibited the charac-
teristics of a stern taskmaster he 
would, nevertheless, go out of his 
way to make up for any injury done 
to a student's feelings. 
Washington Atlee '1829 provided a 
glimpse of what this relationship was 
like in an 1873 address before the 
Alumni Association: 
I matriculated in the fall of 1826, 
and immediately entered the office 
of Professor McClellan. He had a 
large class of private students, and 
was in the habit of quizzing them 
every night on the lectures of the 
preceding day. His manner was 
earnest, his questions minute, and 
he expected prompt and correct 
answers. If he failed in getting such 
a reply, he often became highly 
indignant. On one occasion, while 
examining on the anatomy of the 
heart, a question went from one to 
another unanswered, until it 
reached the youngest member of 
the class—a first course student. 
McClellan could scarcely control 
himself, and after exhibiting his 
disappointment, he exclaimed: "I 
lay my life . . . the youngest student 
here will answer it!" The young 
gentleman knew the question, but 
having been placed in such an 
invidious position, declined to 
answer. The excitement increased: 
"I insist upon it, you know it, and 
you must answer." The reply was 
quietly given. "There, now," said 
McClellan, "are you not ashamed of 
yourselves, gentlemen, some of you 
second and third course students, 
not to be able to answer a simple 
question like that?" When that 
young man left McClellan's office, 
it was with the intention of never 
returning to it again. Two weeks 
passed by and he did not return, 
although he was regular in 
attendance on McClellan's lectures. 
One Saturday, as he was entering 
the lecture room, the Janitor placed 
a note in his hand, which he at 
once recognized as McClellan's 
writing. It read thus: "Do you never 
intend to show the light of your 
countenance in my office again? 
I shall be most happy to see you 
there this evening." The student 
kept his resolution, and did not go. 
Next morning, soon after breakfast, 
the servant summoned him from 
his room, by announcing that a 
gentleman wished to see him in 
the parlor. He went down, and 
who was it but McClellan! "Come, 
come," said he, "put on your hat 
and coat; I want you to ride with 
me this morning." The invitation 
was gladly accepted, the thing 
talked over, explanations were 
made, and promises on both sides 
given, and after dining together at 
his own house, they parted 
friends, and always remained so. 
Soon after Dr. McClellan's death an 
event took place which helped to 
conceal the whereabouts of his last 
residence. All of the published 
accounts, in city directories, college 
announcements, and obituary 
notices, indicated that Dr. 
McClellan's last address was at 
248 Walnut Street. In 1850, or 
thereabouts, the City of Philadelphia 
introduced a new numbering system 
which changed the street address of 
McClellan's former residence to 912 
Walnut Street. Fortunately for us, 
one of the older city directories 
provided a clue that linked both of 
these numbers together. 
DeSilver's Philadelphia Directory and 
Stranger's Guide for 1833 contains 
the following listing: "McClellan, 
Geo., M.D., Professor of Surgery, 
248 Walnut St. abv. 9th." 
Once it was known that the 
McClellan residence stood above 
Ninth Street, a visit to the 
Philadelphia Historical Commission 
led to the discovery of a document 
which listed George McClellan as 
the owner of a house in that 
vicinity. This document, a brief of 
title for 912 Walnut Street, indicated 
that Dr. McClellan purchased the 
property on October 12, 1832 and 
that his widow, Elizabeth Brinton 
McClellan, sold it to a gentleman 
named William Griffith in 1853. 
The file also contained a copy of a 
fire insurance survey, prepared for 
Mr. Griffith, that had the old and 
new street numbers written on it. 
Moreover, this home inspection was 
recorded only six months after 
Elizabeth McClellan sold the 
property. Presumably, the condition 
of the house hadn't changed much 
since her husband's death. 
The survey describes a three-story 
dwelling with a rear extension. The 
house featured up-to-date conveniences 
on the second floor. 
The description of the basement, where 
the barber shop eventually opened, 
deserves particular attention: 
The basement story divided into 
kitchen, dining rooms, short passage 
. . . large pantry closet, kitchen, range 
St boiler, stone sink with hot and 
cold water and a dresser with doors 
and drawers, one plain marble mantle 
. . [and] a furnace in the kitchen 
for warming the house which 
appears safe. 
During the 1960s and '70s, the 
neighborhood around McClellan's old 
home underwent a series of dramatic 
transformations while many of today's 
familiar landmarks were built, such as 
Scott Library, Alumni Hall, the Gibbon 
Building, and the Orlowitz and 
Barringer Residence Halls. Needless to 
say, the scale of this construction 
activity made it necessary to demolish 
dozens of buildings. Eventually, 
McClellan's forgotten home became one 
of the casualties. In 1974 the 
Philadelphia Historical Commission 
granted permission to the 
Redevelopment Authority to tear down 
the structure. The space was incorpo-
rated into a lot which was soon utilized 
for the construction of the Barringer 
Residence Hall. Today, one of Barringer 
Hall's street-level shops, the Wawa food 
market, has the distinction of being 
located at 912 Walnut Street, and, as 
they've been doing for over a century, 
Jeffersonians are still constantly visiting 
this site. 
The close proximity of 912 Walnut 
Street to Wills Eye Hospital (its 
immediate neighbor to the east) consti-
tutes the last historical irony in this tale, 
given the fact that George McClellan 
established Philadelphia's first eye 
hospital in 1821. McClellan's 
"Institution for the Diseases of the Eye 
and Ear" lasted for approximately four 
years. It was superseded, in 1825, by the 
creation of the Wills Eye Hospital, 
which benefited from a Philadelphia 
merchant's hundred thousand dollar 
legacy. It has been speculated that 
McClellan diverted his energies from his 
fledgling eye clinic to the establishment 
of Jefferson Medical College as a result 
of his knowledge about the legacy, and 
his realization that it would be 
impossible to compete financially with 
such a rival. Wills Eye Hospital 
relocated to its present location from its 
previous home at46th and Spring 
Garden in 1980.11) 
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APPOINTMENTS 
Bolognese Appointed Chair 	 Mancall is Interim Chair 
of Obstetrics and Gynecology of Neurology 
David M. Capuzzi, M.D.'64, Ph.D. 
has been appointed 
Director of the newly 
formed Cardiovascular 
Disease Prevention 
Center. 
Dr. Capuzzi previously 
served for a decade as Chief of 
Endocrinology, Diabetes, 
Metabolism, and Lipid 
Disorders at Allegheny 
University Hospitals. He 
brings years of experience in 
managing lipid disorders and 
other risk factors that 
accelerate cardiovascular 
disease. He has helped 
demonstrate that effective 
often predict the onset 
of premature labor. 
Jefferson's department 
boasts particular 
strength in maternal-
fetal medicine, 
• high-risk obstetrics, 
and gynecologic 
oncology. 
One of Dr. Bolognese's primary 
goals will be to integrate the 
services of the department of 
obstetrics and gynecology 
throughout the Jefferson 
Health System. In addition, he 
plans to help build a research 
division within the department 
that will seek additional grant 
support for clinical research 
from national and international 
sources. Ultimately, Dr. 
Bolognese hopes to develop a 
center that will emphasize 
women's and children's health 
services throughout JHS. 
diagnosis and 
management of the 
factors that cause heart 
attack, stroke, and 
related conditions can 
produce stabilization 
of the disease and 
even reversal. 
Dr. Capuzzi's work has been 
published in the New England 
Journal of Medicine, Cell 
Biology, the Journal of 
Biological Chemistry, and the 
Journal of Cell Biology. Dr. 
Capuzzi earned his Ph.D. in 
physiological chemistry from 
Johns Hopkins, where he 
completed his residency and 
fellowship. 
EI llio tt Mancall, M.D. has 4 
been named Interim 
Chairman of Neurology. Dr. 
Mancall has been a Professor 
of Neurology at Jefferson 
since 1995, and also taught 
here from 1958 to 1965; he 
was Chairman of Neurology at 
Hahnemann University from 
1976 to 1994. 
re Department of 
Elleurology is expanding 
its state-of-the-art services 
with the establishment of a 
Headache Center in addition 
to the new Comprehensive 
Epilepsy Center and the 
Stroke Center. 
The Headache Center, 
formerly located at 
Germantown Hospital, 
provides the latest in compre-
hensive care and research. Its 
Director is Stephen D. 
Silberstein, M.D., and Co-
Director is William B. Young, 
M.D. Also on staff is Jeffrey 
M. Dayno, M.D., who is 
Associate Director of the 
Jefferson Stroke Center. The 
Stroke Center is directed by 
Rodney D. Bell, M.D., and 
ndrew Freese, M.D., 
h.D. has been appointed 
Associate Professor of 
Neurosurgery and Director of 
Dr. Mancall has received 
numerous awards for his 
teaching ability, including the 
1997 Baker Award from the 
American Academy of 
Neurology. He has published 
on neurological complications 
of chronic alcoholism, 
malnutrition, and systemic 
malignancy. it 
also includes neurointen-
sivist David G. Brock, M.D. 
The Comprehensive Epilepsy 
Center, directed by Michael 
R. Sperling, M.D., is one of 
the largest epilepsy programs 
in the world. It offers 
complete outpatient care 
using both standard and 
investigational drugs, a full 
array of diagnostic services 
including video EEG 
monitoring, an interna-
tionally renowned epilepsy 
surgery program, genetic 
counseling, specialty care 
during pregnancy, neuropsy-
chological evaluations, 
psychological care, cognitive 
rehabilitation, social support, 
and community 
education. 
Neurosurgery Research. He 
brings to Jefferson and Wills 
Eye Hospitals added 
experience in general and 
Rvarld J. Bolognese, .D. has been 
appointed the Paul A. 
and Eloise B. Bowers 
Professor and 
Chairman of Obstetrics 
and Gynecology. He 
comes to Jefferson 
after 26 years at Pennsylvania 
Hospital, the last 11 of them as 
Chairman of Obstetrics and 
Gynecology. 
Dr. Bolognese brings years of 
experience in general obstetrics 
and gynecology and a 
specialized interest in 
maternal-fetal medicine. He has 
studied the identification and 
treatment of premature labor 
and premature membrane 
rupture, which account for well 
over 50 percent of pregnancy 
losses. He has also researched 
the use of ultrasound to 
identify cervical changes that 
Capuzzi Directs Cardiovascular 
Disease Prevention Center 
Neurology Options Expand 
with Headache Center, Stroke 
Center, and Epilepsy Center 
Freese Directs 
Neurosurgery Research 
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AtlantiCare Health System Announces Exclusive 
Partnership with Jefferson and duPont Hospital 
functional neurosurgery, 
including contemporary 
surgical approaches to spine 
disorders and brain tumors. 
He will be performing 
functional surgery for 
epilepsy, Parkinson's disease 
and other movement 
disorders, and pain. 
As director of neurosurgery 
research at Jefferson, Dr. 
Freese also supervises a large 
research program, including 
several initiatives for the 
development of gene therapy 
for Parkinson's disease, 
epilepsy, cerebrovascular 
disorders, and pituitary 
tumors. He is co-founder 
and Executive Director of 
the Parkinson's Disease 
Gene Therapy Consortium. 
Dr. Freese has performed 
basic studies on the 
biochemistry of 
Huntington's and 
Alzheimer's diseases, and 
developed new drug delivery 
systems for neurological 
disorders. He has 
contributed to more than 
100 scientific publications, 
has edited several books and 
journals, and has organized 
international scientific 
conferences on gene therapy 
for neurological disorders. 
Freese comes to Jefferson 
and Wills Eye from the 
University of Pennsylvania, 
where he was a member of 
the Institute for Human 
Gene Therapy. He was also 
Director of the Laboratory of 
Molecular Neurosurgery at 
Graduate Hospital. He 
received his Ph.D. from the 
Massachusetts Institute of 
Technology, and did his 
surgical and neurosurgical 
training at the University of 
Pennsylvania. 4 
AtlantiCare Health System nd Atlantic City 
Medical Ccnter (ACMC) will 
join forces with duPont 
Hospital for Children, the 
pediatric affiliate of Thomas 
Jefferson University, to 
collaborate on an exclusive 
pediatric affiliation. This 
agreement, once completed, 
will be the first of its kind in 
southeastern New Jersey and 
is the initial step in the 
development of a compre-
hensive regional children's 
program. 
The agreement will link 
duPont's and Jefferson's 
renowned clinical services, 
specialty care, and teaching 
programs with the 
AtlantiCare Health System. 
These services will be 
available at ACMC and at the 
new AtlantiCare Healthpark 
in the English Creek section 
of Egg Harbor Township. 
The duPont Hospital for 
Children is located in 
Wilmington, Delaware. 
Together, duPont and 
Jefferson provide pediatric 
care for close to 200,000 
from across the country 
annually. 
The affiliation represents a 
significant expansion of 
duPont and Jefferson's 
presence outside the 
Philadelphia region and will 
bring renowned pediatric 
specialists from both duPont 
and Jefferson to this region. 
The duPont and Jefferson 
doctors will collaborate with 
local southeastern New 
Jersey primary care pediatric 
physicians in building a 
world-class pediatric 
program for the residents of 
southeastern New Jersey. 
According to AtlantiCare 
President and CEO George 
Lynn, the agreement is a 
result of an extensive 
planning process, which 
included local physicians, 
ACMC, duPont, and 
Jefferson. 
"We are delighted that this 
affiliation will bring the 
expertise of not one, but two 
outstanding partners to the 
community that we serve," 
says Lynn. "Our goal at 
AtlantiCare is to give area 
children the very best 
possible care. And together, 
AlantiCare, duPont, and 
Jefferson will make that a 
reality by combining their 
expertise with that of our 
area's primary care pediatri-
cians," added Lynn. "This 
will complement our other 
initiatives focusing on 
children, such as Success 
By 6® and AtlantiCare Kids." 
The agreement calls for 
duPont and Jefferson to 
assist in the management and 
operation of inpatient 
pediatric units in both the 
City and Mainland Divisions 
of ACMC, including the 
Neonatal Intensive Care Unit 
at the City Division. They 
will also support the 
pediatric services provided in 
ACMC's emergency depart-
ments and provide pediatric 
subspecialties and pediatric 
surgery at AtlantiCare 
facilities. At these locations, 
duPont and Jefferson will 
assist AtlantiCare in coordi-
nating specialty care for 
children, including 
cardiology, neurology, and 
gastroenterology. 
Long-term plans may include 
duPont surgeons performing 
surgery at the new 
AtlantiCare Surgery Center in 
AtlantiCare HealthPark. 
"Together we are building a 
new model for the delivery of 
world-class pediatric care," 
says ACMC President David 
Tilton. "As we move forward, 
we'll be evaluating the most 
effective and efficient ways to 
deliver that care, including 
the appropriate access 
points." 
Commenting on the 
duPont/Jefferson expansion 
into southeastern New Jersey, 
Paul C. Brucker, M.D., 
President, Thomas Jefferson 
University, says, "We are 
looking forward to bringing 
our expertise to the shore 
region, and we are especially 
pleased that we will be able 
to do so in partnership with 
one of the region's leading 
health tare providers." 
AtlantiCare Health System is 
an integrated network of 
services with a vision of 
improving health outcomes 
and health status and 
reducing costs for people 
who live and work in 
southeastern New Jersey. 
AtlantiCare is composed 
ofAtlantic City Medical 
Center, AtlantiCare 
Foundation, AtlantiCare 
Health Plans, AtlantiCare 
Behavioral Health, 
AtlantiCare Health Services, 
and InfoShare, an 
information technology 
company. 
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Dr. and Mrs. Rodgers beside the portrait, surrounded by family 
Jefferson's Newest Painting 
Honors Dr. Rodgers 
The 31st annual James L. A. Roth Visiting Professorship 
was delivered by (at left) Albert J. Czaja Jr., M.D., Professor of 
Medicine at the Mayo Clinic. Following his lecture, "Evolving 
Concepts and Treatment of Autoimmune Hepatitis," Dr. Czaja 
poses with (at center) James L. A. Roth, M.D., for whom the 
visiting professorship is named. Dr. Roth is a past Chief of 
Gastroenterology at Presbyterian Medical Center and Editor of 
the fourth edition of Bockus's Gastroenterology. At right is 
Anthony J. DiMarino Jr., M.D., the Rorer Professor of Medicine 
and Director of Gastroenterology and Hepatology. 
ON CAMPUS 
Women's Liaison Task 	 a medical student represen- 
. 
orce has formed at 	 tame. 
Jefferson, and already has 
several activities to foster 
networking and address issues 
pertinent to women in 
medicine. 
Women's Liaison Task Force 
Begins Array of Activities 
Artrait of Joseph F. Odgers '57, Associate 
Dean for Residency and 
Affiliated Hospital Programs, 
was presented to the university 
by his colleagues and friends. 
Presiding at the presentation 
was Dr. Rodgers's colleague in 
the dean's office, James B. 
Erdmann, Ph.D., Associate 
Dean for Administration and 
University Registrar. 
Dr. Rodgers has spent most of 
his career at Jefferson. A 
specialist in infectious 
diseases, he earned respect for 
his diagnostic knowledge and 
his empathy, and was elected 
to a term as President of the 
Volunteer Faculty Association. 
He was appointed an Associate 
Dean in 1984. 
Joseph S. Gonnella, M.D., 
Dean and Senior Vice 
President for Academic Affairs, 
with whom Dr. Rodgers has 
worked for many years, 
accepted the portrait (painted 
by Dean Paules) on behalf of 
the faculty. With gentle 
amusement Dr. Gonnella 
recalled how, throughout his 
career, Dr. Rodgers has 
unhesitatingly stood up for 
what he believed in. "He tells 
you what you should know, 
not what you want to 
believe." 
Accepting the portrait for the 
university, President Paul C. 
Brucker, M.D. credited Dr. 
Rodgers with filling an 
important role behind the 
scenes. "Getting hospitals and 
hospital directors to work 
together is difficult. Quietly 
and efficiently, Joe Rodgers 
gets things done." 
Biographical sketches of the 
honoree were given by 
Francis E. Rosato, M.D., The 
Samuel D. Gross Professor 
and Chairman of Surgery, and 
Warren P. Goldburgh '52, 
Honorary Clinical Professor of 
Medicine, who was Dr. 
Rodgers's practice partner 
early in his career. 
Dr. Rosato praised the 
honoree for "injecting 
trust—a terribly important 
thing—into our relationships 
with our affiliates," and for 
defending the rights and 
needs of the house staff. Dr. 
Rodgers, he said, "has always 
been there when Jefferson 
needed him." it 
Part of the spark to organize 
the task force came from the 
Association of American 
Medical Colleges, which 
established a nationwide 
system of Women's Liaison 
Officers appointed by deans of 
medical schools. Jefferson's 
officer is Karen D. Novielli 
'87, a faculty member in 
Family Medicine. 
Dr. Novielli, in turn, 
organized Jefferson's Women's 
Liaison Task Force which 
meets monthly. Each 
department has appointed a 
representative, and there is a 
house staff representative and 
To promote communication, 
the task force distributes a 
newsletter (for information, 
contact Susan Parks, M.D. at 
parksl@jeflin.tju.edu or via 
voice mail 215 955 5266 ext. 
91529). 
In October the task force 
hosted its first annual 
reception. The speaker was 
Loretta Finnegan, M.D., who 
was a member of Jefferson's 
faculty prior to her 
appointment as Director of 
the National Institutes of 
Health's Women's Health 
Initiative, a multicentered trial 
enrolling 164,000 women. As 
a way to promote networking 
and socializing, many faculty 
members sponsored a medical 
student to attend the 
reception as well. it 
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This Magazine, One of the Oldest 
of its Kind, Reaches its 75th Year 
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Following the 1997 Grandon Lecture, Dr. and Mrs. Raymond 
C. Grandon '45 and University President Paul C. Brucker, 
M.D. go to the podium to congratulate speaker Karen Ignagni, 
President and CEO of the American Association of Health 
Plans, who spoke on "The Future of Managed Care and 
Academic Medicine." 
The first annual 
Jimmy Brent Concert 
was held October 30 in 
the Lillian and Robert 
Brent Auditorium, 
which was named in 
1996 in honor of 
Robert L. Brent, 
M.D., Ph.D., the 
Distinguished Professor 
and longtime 
Chairman of Pediatrics, and his wife Lillian. 
The concert is a memorial to their son Jimmy. Held each 
year, it brings talented young musicians from Philadelphia's 
world-renowned Curtis Institute to perform at Jefferson. Thus 
the concert brings a humanist outlook to the medical campus. 
Among the works performed were ones written by Jimmy Brent, 
an accomplished musician. 
(Below) members of the Brent clan gather before the concert, 
which was attended by numerous friends, colleagues, and 
students of Dr. Brent. 
With this issue, the Jefferson Medical College 
Alumni Bulletin has seen 75 
years of continuous 
publication under the same 
name. It's always had the 
same mission: news about the 
college and about its alumni. 
One of Jefferson's strengths is 
its exceptional stability, and 
this has been reflected in the 
magazine. Other medical 
schools may have superb, big-
budget publications, but 
almost none is as enduring as 
ours. Even the Harvard 
Medical Alumni Bulletin, 
though it was founded in 
1892, ceased at certain points 
and has only been continuous 
since 1927. The Bulletin of the 
University of Maryland School 
of Medicine does have a slight 
edge on us, having started in 
1916. Yale's medical alumni 
publication began in the 
forties, and those of the 
University of Pennsylvania, 
Dartmouth, and Johns 
Hopkins are positively 
youngsters. 
In December 1922, when the 
first issue of the Jefferson 
Medical College Alumni 
Bulletin came off the press, the 
college occupied a structure 
located where the Curtis 
Building (itself historic-
looking to modern eyes) now 
stands. The hospital was 
simply what we call "Old 
Main"—even Thompson had 
not been built. W. W. Keen 
'1862, world-renowned 
neurosurgeon, was still partic-
ipating in consultations, and 
J. Chalmers DaCosta '1885, 
author of a surgery text used 
at most medical schools, was a 
Co-Chairman of Surgery. John 
H. Gibbon Jr. '27, later to 
become famous for the heart-
lung machine, was not even a 
student yet. 
Three-quartets of a century 
later, Jefferson continues its 
strong position, and the 
Bulletin reflects this in print 
and in an electronic version 
on the World Wide Web 
(http://jeffline.tju.edu/CWIS/ 
JMC/alumnilbulletin.html). 
Complete sets of the Bulletin 
are maintained by the 
National Library of Medicine 
in Washington as well as 
Jefferson's Scott Library and 
the Alumni Office. 
—Malcolm Clendenin 
The Class of 2001 at a Glance 
/223 students matriculated this fall at Jefferson Medical College 
(350 were accepted out of approximately 10,000 total applicants) 
/90 are female, 133 are male 
/12 are members of minorities 
/They come from 27 different states and the Virgin Islands, and 
attended 98 different colleges 
/26 are in the DIMER (Delaware Institute of Medical Education and 
Research) program for students from Delaware 
/18 are in the six-year, accelerated B.S./M.D. program with Pennsylvania 
State University 
/10 are participating in the Physician Shortage Area Program which 
funnels graduates to practice in underserved areas 
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FACULTY AND STUDENTS EARN MAJOR 
Patrick V. Acevedo '98 was 
selected a National Medical 
Fellow, an honor accorded 35 
minority students displaying 
the knowledge, skills, and 
experience needed for a career 
in academic medicine. He is 
involved in intercellular 
research on prostate cancer 
under the guidance of faculty 
mentor W. Edward Mercer, 
Ph.D., Professor of Micro-
biology and Immunology. 
Previously Patrick had been 
awarded the Sandoz 
Pharmaceuticals Prize for 
Research in Immunology and 
Oncology in 1992 and 1994. 
Robert L. Brent, M.D., Ph.D., 
the Distinguished Professor of 
Pediatrics, has been elected to 
membership in the Institute of 
Medicine of the National 
Academy of Sciences. He was 
given this honor on the basis 
of his research achievement 
and his involvement with 
critical issues affecting the 
public's health, in particular 
the causes and prevention of 
birth defects. Dr. Brent is 
Jefferson's first pediatrician to 
be elected to the academy. 
Thomas Jefferson University 
honored him in 1996 by 
creating the Brent 
Professorship which is held by 
the Chairman of Pediatrics, 
and by the naming of the 
Lillian and Robert Brent 
Auditorium. 
Steven J. DiBiase, M.D., 
Resident in Radiation 
Oncology, has been selected 
as an American Society for 
Therapeutic Radiology and 
Oncology (ASTRO) Research 
Fellow for 1997-98. Dr. 
DiBiase is conducting basic 
research with George Iliakis, 
Ph.D., Professor of Radiation 
Oncology, evaluating p53 
mutations and their effects 
on cell radiosensitivity and 
DNA repair. 
Stephen A. Feig, M.D., 
Professor of Radiology, was 
elected Vice President of the 
Society of Breast Imaging at 
its annual meeting in April 
1997. The SBI membership 
consists of 1,700 radiolo-
gists from the United States 
and abroad who subspe-
cialize in breast imaging. 
Kelly Herbert, Class of 
2000, was recently awarded 
a $3,000 scholarship by the 
Alpha Omega Alpha Honor 
Medical Society for her 
study of how chemotherapy 
can sensitize cancer cells to 
respond to lower levels of 
radiation treatment so that 
nearby healthy cells are less 
affected. She was one of 40 
AOA National Research 
Award Scholarship winners 
for 1997. 
Ronald P. Jensh, Ph.D., 
Professor of Pathology, 
Anatomy, and Cell Biology, 
received the Bucknell 
University Alumni Award 
for outstanding 
achievement in a 
profession. Dr. Jensh's 
research focuses on 
preventing birth defects, 
and applying innovative 
technology to biomedical 
education. 
Evelyn J. Mackin, P.T., 
Director of the Hand 
Rehabilitation Foundation, 
was honored in San Diego 
in September at the annual 
meeting of the American 
Society of Hand Therapists. 
She is the founder and past 
President of the American 
Society of Hand Therapists, 
Founder and first President 
of the International 
Federation of Societies of 
Hand Therapists, as well'as 
the Founder and first 
Editor-In-Chief of the 
Journal of Hand Therapy 
which has a worldwide 
readership. With James M. 
Hunter '53 and Anne D. 
Callahan, 0.T., Mrs. 
Mackin is coeditor of the 
book Surgery and 
Rehabilitation of the Hand. It 
is in its fourth edition, and 
is considered the bible of 
hand rehabilitation. Mrs. 
Mackin has been with the 
Philadelphia Hand Center, 
an affiliate of Jefferson, for 
30 years. The annual hand 
surgery symposium co-
sponsored by Thomas 
Jefferson University, which 
she also co-chairs, will have 
its 23rd anniversary in 
March 1998. 
S. Grant Mulholland, 
M.D., The Nathan Lewis 
Hatfield Professor and 
Chairman of Urology, is the 
recipient of the 1997 
Alumni Achievement 
Award from the Temple 
University School of 
Medicine. Dr. Muholland 
has served on the editorial 
boards of the Journal of 
Investigative Urology 
and Ostomy/Wound 
Management. He has 
published more than 120 
articles in leading journals. 
Dr. Mulholland is past 
President of the Mid-
Atlantic Section of the 
American Urological 
Association. 
David B. Nash, M.D., 
M.B.A., Associate Dean for 
Health Policy and Director 
of Health Policy and 
Clinical Outcomes, has 
been named the 1997 
individual Health Care 
Hero by the Philadelphia 
Business Journal for his 
contributions regionally 
and nationally toward 
improving health care 
quality and lowering costs. 
Among other activities, Dr. 
Nash serves as Associate 
Director of Partnerships for 
Quality Education, a 
national Pew Charitable 
Trusts program to bring 
together academic medical 
centers and managed care 
organizations. He also 
serves on the National 
Performance Council of the 
Joint Commission on 
Accreditation of Healthcare 
Organizations, and is Vice 
Chairman of the American 
Medical Association's 
Physician Measurement 
Advisory Committee. 
Mark K Ono R0'97, 
Chief Resident in Radiation 
Oncology this past year, 
received a 1997 American 
Radium Society Visiting 
Oncologist Award. Dr. Ono 
used the award to enhance 
his Jefferson residency 
education by participating 
in a subspecialized elective 
rotation at the University of 
California, San Francisco. 
Charlene J. Williams, 
Ph.D., Research Associate 
Professor, Division of 
Rheumatology, Department 
of Medicine, has been 
awarded a four-year grant 
of $956,884 from the 
National Institutes of 
Health entitled "Molecular 
Characterization of Familial 
Chondrocalcinosis." 
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Dr. Carol Artlett Earns Awards for Scleroderma Research 
Are women who have been ..pregnant more vulnerable 
to certain autoimmune diseases 
such as scleroderma? For her 
study of this question, Carol 
Artlett, Ph.D., postdoctoral 
fellow in rheumatology, has 
received two grants and The 
Pennsylvania State University's 
Finkelstein Award. 
Along with J. Bruce Smith, 
M.D., Professor of Medicine, 
and Sergio A. Jimenez, M.D., 
The Dorrance H. Hamilton 
Professor of Medicine, Dr. 
Artlett investigates the 
connection between sclero- 
derma and fetal cells found in 
systemic sclerosis patients. 
Recently, it was discovered that 
fetal cells which pass from the 
fetus to the mother can survive 
in the maternal circulation for 
many years after the birth of 
the child. Dr. Artlett identified 
the presence of fetal cells in the 
affected skin of patients with 
scleroderma and hypothesized 
that these cells are inducing a 
response similar to Graft-
Versus-Host Disease (GVHD) 
in these patients. Her research 
team proposed to identify and 
characterize the cells to gain a 
better understanding of the 
involvement that these fetal 
cells have in scleroderma, and 
to test the hypothesis that 
GVHD induced by these fetal 
cells may cause scleroderma in 
some patients. This work could 
possibly lead to novel 
therapeutic methods to target 
these foreign cells and 
ultimately to cure the disease. 
For this project, Dr. Artlett 
received a postdoctoral 
fellowship award from the 
American College of 
Rheumatology, and also was 
one of nine investigators 
nationwide to receive a sclero-
derma research grant funded 
jointly by the Scleroderma 
Federation and the United 
Scleroderma Foundation. 
The Finkelstein Award, 
established in 1974 by The 
Pennsylvania State University's 
Hershey Medical Center, 
recognizes a researcher in 
training from among the 
Commonwealth's six medical 
schools for the most original 
work in a scientific paper. 
Additional criteria are clinical 
importance, effort expended 
and clarity of presentation. it 
Botulism Vaccine Developed by Environmental Medicine Faculty 
Molecular biologists at Jefferson have created an 
oral vaccine against botulism. 
The researchers believe that 
such a vaccine could be used as 
a prototype in developing 
future vaccines for other 
diseases such as diphtheria, 
whooping cough and tetanus. 
Eventually, they say, their 
discovery may lead to a range 
of oral vaccines that could be 
inserted into common foods. 
Lance Simpson, Ph.D., 
professor of medicine, Jefferson 
Medical College, and director 
of the Jefferson Clinical Center 
for Occupational and 
Environmental Medicine, and 
his colleagues, Nikita Kiyatkin, 
Ph.D., and Andrew 
Maksymowych, Ph.D., used the 
sophisticated tools of molecular 
biology to create a modified 
and non-toxic version of 
botulinum toxin, which is 
nature's deadliest poison. The 
toxin, which is the cause of the 
disease botulism, is ordinarily 
encountered as a form of food 
poisoning. When someone 
ingests the toxin, it survives 
the harsh conditions of the 
gastrointestinal system and 
moves into the general 
circulation. It is eventually 
delivered to the central nervous 
system and causes paralysis. 
The researchers have created a 
novel form of the toxin that 
retains the ability to survive the 
GI system and enter the general 
circulation, yet no longer can 
poison nerves. As a result, the 
novel molecule is an effective 
oral vaccine against botulism. 
The scientists, reporting in 
November in the journal 
Infection and Immunity, detail 
the results of experiments in 
which they successfully 
immunized mice against 
botulism. 
One immediate use of a 
botulism vaccine, Dr. Simpson 
notes, would be in veterinary 
medicine. Animals such as 
racehorses and farmyard 
chickens are susceptible to the 
disease, making such a vaccine 
of interest to the pharmaceu-
tical industry. 
According to Dr. Simpson, 
there may be far greater 
applications of the work in 
both veterinary and human 
medicine. 
"The very properties that this 
molecule possesses are the ones 
that would be essential for all 
oral vaccines," he explains. 
"The molecule could be used as 
a carrier to transport other 
potential vaccines from the 
gastrointestinal system into the 
general circulation, where they 
would evoke antibodies. If this 
were to work, the novel carrier 
molecule could be the critical 
element needed to create a host 
of new oral vaccines." 
One use of this vaccine 
technology would be for 
common diseases such as 
diphtheria and tetanus. Dr. 
Simpson sees a possibility for 
an even more intriguing use. 
"There are Third World 
countries in which injectable or 
even oral vaccines are still not 
practical; the health systems 
and finances are inadequate," 
he explains. "What might be a 
more practical solution is to 
put the genes for the carrier-
vaccines into a plant such as a 
banana. As the banana grows, 
it would automatically 
synthesize the oral vaccines. 
Whenever a person ate the 
banana, that person would also 
be consuming oral vaccines. 
This might be a way to combat 
illnesses that are endemic to 
some parts of the developing 
world." 
Dr. Simpson and his colleagues 
are now constructing the genes 
that will encode the carrier-
vaccine molecules. They will 
test the ability of the molecules 
to act as oral vaccines in the 
laboratory. If the work is 
successful, the next step will 
be to conduct human trials. 
Via Jefferson's Public Relations 
office, this discovery gained 
attention on the ScienceNOW 
Website of the American 
Association for the Advance-
ment of Science, as well as 
WHYY-FM, the Philadelphia 
affiliate of National Public 
Radio. 
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Genetic Test. Identifies Uterine Novel Facility is Established 
Tumors as Malignant or Benign for Cancer Vaccine Processing 
Ri
searchers at Jefferson 
ave developed a new 
genetic test that uses reverse 
transcriptase-polymerase 
chain reaction (RT-PCR) to 
identify uterine tumors as 
malignant or benign. The test, 
which is more definitive than 
the routine tests currently in 
use, looks for the presence or 
absence of the gamma-smooth 
muscle isoactin gene. This 
gene, whose absence 
correlates positive with 
malignancy, represents a 
unique molecular marker of 
uterine cancer. These findings 
appear in the July issue of 
Cancer. 
The study, led by Kirk 
McHugh, Ph.D., Associate 
Professor of Pathology, 
Anatomy, and Cell Biology, 
and the person who first 
identified the gamma-smooth 
muscle isoactin gene, lends 
new hope to women with 
uterine fibroid tumors whose 
diagnosis is inconclusive. 
"Uterine fibroids account for 
one-third of gynecologic 
hospital admissions," 
explained Dr. McHugh. "Most 
are diagnosed as benign 
leiomyomas, but four to five 
percent are malignant 
leiomyosarcomas. Some other 
tumors fall into a so-called 
grey zone, with test results 
proving inconclusive." 
According to Dr. McHugh, 
current tests cannot conclu-
sively identify these grey zone 
tumors, or "tumors of 
uncertain malignant 
potential," as benign or 
malignant. "To err on the side 
of caution, many times 
women with tumors of this 
type undergo hysterectomies 
to protect against the chance 
that cancer is present. Our 
test provides a definitive 
answer that may spare these 
women unnecessary surgery 
and loss of their reproductive 
organs. 
RT-PCR is a highly sensitive, 
diagnostic test that identifies 
a tumor as benign if the 
gamma-smooth isoactin gene 
is present, and malignant if 
the gene is not present. 
"There is no grey zone with 
this test," says McHugh. "It 
gives a clear yes or no answer, 
providing a definitive 
diagnosis of cancer, lending 
protection against potentially 
unnecessary surgery and 
follow-up radiation therapy as 
well as providing peace of 
mind for those women 
diagnosed with benign 
tumors." 
The new genetic test is not 
part of the standard battery of 
pathologic tests 
recommended for uterine 
tumor tissue biopsies, but is 
currently under experimental 
use at Jefferson. The test acts 
as a definitive second 
opinion, especially important 
for women of child-bearing 
age who have been told that 
they may have cancer and 
should probably have a 
hysterectomy. "Undergoing a 
hysterectomy is an unsettling 
experience for women of any 
age, but can be especially 
devastating for a young 
woman who is hoping to bear 
children," explains Dr. 
McHugh. "For this small 
population of women, a 
definitive diagnosis of benign 
versus malignant is 
critical." 
efferson Medical College is 
now home to a unique 
cancer vaccine processing 
facility. It is the only one of its 
kind in Philadelphia, and 
possibly the nation. 
AVAX Technologies, Inc., of 
Kansas City, Missouri—which 
has exclusive rights to a 
Jefferson-based vaccine 
against malignant 
melanoma—is building the 
vaccine laboratory to increase 
quantities of the vaccine for 
future testing and use. The lab 
is a so-called "clean lab," 
which means it meets strict 
federal Food and Drug 
Administration standards. 
"If a company wants to 
produce a vaccine to market, 
the work must be done in an 
approved facility. It's called a 
Good Medical Practices lab," 
explains Professor of 
Medicine David A. Berd '68, 
who created the vaccine 
technology. "It essentially will 
be an industrial lab in an 
academic facility." 
Dr. Berd and his colleagues 
are hoping that the $200,000 
laboratory will help step up 
the production of the 
potentially life-saving cancer 
vaccine. 
The current vaccine is 
autologous, meaning that it's 
prepared from a patient's own 
cancer cells. Each vaccine is 
custom-made for the patient. 
Before injecting the cells into 
patients, the cells are inacti-
vated and treated with a 
chemical, dinitrophenyl, 
which chemically modifies 
them. The modified cells 
apparently appear foreign 
enough to the body's immune 
system for it to react against 
them. 
The vaccine treatment appears 
to be effective in prolonging 
the survival of patients with 
malignant melanoma. In the 
June 1997 issue of the Journal 
of Clinical Oncology, Dr. Berd 
reported the results of 
treatments on patients with 
melanoma spread to a single 
lymph node site (stage III 
disease). The vaccine 
treatments were started after 
the lymph nodes had been 
removed. Of 62 patients, 36 
were still alive after a median 
follow-up time of 55 months. 
The projected five-year 
relapse-free and overall 
survival rates for these 
patients were 45 percent and 
58 percent respectively. This 
compares favorably with the 
15- to 25-percent survival 
rates reported in patients 
treated with surgery alone. 
Dr. Berd and his colleagues 
will participate in a Phase III 
trial to test the effectiveness of 
the vaccine on patients with 
disease that has spread to the 
lymph nodes. The five-year 
trial, already underway, will 
compare the effectiveness of 
an autologous melanoma 
vaccine to the standard 
treatment, which is alpha 
interferon. The trial will 
involve 250 patients seen at 
institutions in several major 
cities. If the trial is successful, 
then AVAX will ask the FDA 
for approval to allow it to 
market the vaccine. 
The new lab will not be 
limited to vaccines for 
melanoma. Dr. Berd currently 
continues at right 
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Breast Cancer Specialists, Meeting at Jefferson, 
Agree on Means for Classifying Controversial Early Stage Cancer 
In a very unusual move, 
three medical journals are 
concurrently publishing the 
findings of 20 breast cancer 
specialists from Jefferson and 
around the world. They have 
designed a system for classi-
fying ductal carcinoma in situ 
(DCIS), a controversial 
malignancy found in the 
breast, as a first step toward 
improving patient treatment 
for this type of early breast 
cancer. DCIS currently 
represents 20 to 25 percent of 
all breast cancers diagnosed. 
In a paper to be published 
concurrently by Cancer, 
Human Pathology, and The 
Breast Journal, the interna-
tional Consensus Conference 
Committee outlines a classifi-
cation system for DCIS that 
takes into account how the 
cancer's cells appear under the 
microscope (nuclear grade), 
the amount of necrosis, the 
cells' arrangement 
(polarization), and their 
continued from left 
is testing a similar vaccine for 
ovarian cancer. 
Berd explains that many labs 
are working on generic cancer 
vaccines, but few have 
attempted autologous 
vaccines because of the 
technical difficulty involved in 
producing a vaccine for each 
individual patient. "We expect 
to show that our autologous 
cancer vaccine is not only 
effective, but also practical 
and applicable to large 
numbers of patients at sites 
throughout the country," he 
says. # 
physical shape (architecture). 
The consensus conference was 
hosted by Jefferson and chaired 
by Gordon Schwartz, M.D., 
M.B.A., Professor of Surgery. 
"Now when DCIS is encoun-
tered in Timbuktu, it will be 
classified the same way as in 
Philadelphia or Washington or 
London," says Dr. Schwartz. 
The committee members 
include pathologists, mammog-
raphers, surgeons, a radiation 
oncologist, and a biostatis-
tician, from Jefferson and 
medical institutions around the 
globe. 
The report's significance in 
determining the recommended 
approach for DCIS is 
confirmed by the fact that three 
journals have agreed to publish 
the paper at the same time. Dr. 
Schwartz explains that "three 
of the physicians participating 
in the conference are also the 
editors-in-chief of the three 
journals. They thought it was 
important enough to reach all 
three journal audiences." 
Although a majority of patients 
with DCIS will not develop a 
more threatening cancer, in 
some patients, the DCIS can 
progress to become an 
invasive, life-threatening 
malignancy. "Until now, the 
greatest challenge for 
physicians who treat DCIS has 
been to discriminate between 
the less aggressive and more 
aggressive cases," Schwartz 
says. As a result, the treatment 
of DCIS has ranged from 
mastectomy to a combination 
of lumpectomy and radiation 
treatment to lumpectomy 
alone, depending on the 
physician's judgment. 
"If you can't define it, you can't 
treat it properly," he said. "The 
subtleties of classification are 
such that the treatments may 
be different based upon how 
the subtleties of DCIS are 
perceived. So we wanted to get 
these experts to agree upon a 
uniform system of classifi-
cation." 
The consensus of the 
specialists was to identify a set 
of factors in descending order 
of importance: 
3How the cancer cells appear 
on the miscroscope (nuclear 
grade). The cells can have one 
of three appearances: biologi-
cally aggressive; biologically 
non-aggressive; or a state 
between these two. The 
conference determined that the 
more aggressive the cells are, 
the greater the chance of 
subsequent recurrence. 
3Amount of tissue death 
(necrosis): The conferees 
concluded that the more 
cellular death found, the 
greater the chance the cancer 
might recur. 
3Cell formation (polarization): 
The specialists determined that 
cells that are well organized or 
in good formation are more 
likely to be less threatening 
than cells in a loose formation. 
3Physical shape (architecture). 
Cell patterns were categorized 
by the conference into five 
types: 
• Comedo (previously 
considered the type most likely 
to recur) 
• Cribriform 
• Papillary 
• Micropapillary 
• Solid 
The conferees also concluded 
that the size and distribution 
of the DCIS should also be 
taken into account in classi-
fying the cancer. As part of 
their report, the breast cancer 
specialists recommended a 
process for removing and 
evaluating breast tissue for 
DCIS, and recommended that 
a radiologist, surgeon, and 
pathologist work as a unified 
team in this effort. The 
conferees suggested that the 
traditional surgical procedure 
involving a needle-guided 
localization be employed in 
removal of the tissue sample. 
It is also recommended that 
metallic clips be placed on the 
tissue specimen near the site 
of the DCIS if the flakes 
shown on the mammogram 
are faint or within a very 
small area of the specimen. 
It was also recommended by 
the conferees that biologic 
markers such as estrogen and 
proestrogen receptors or 
nuclear proliferation antigen 
Ki-67, for example, be 
determined in each case, 
although these markers are 
not currently used to 
determine treatment. 
Dr. Schwartz notes that 
Jefferson is in the forefront in 
the use of these biologic 
markers. Now that the 
conference has determined a 
means for better identifying 
DCIS, the next step is to 
determine a universally 
acceptable clinical use for the 
classification system, the 
conference report states. The 
conferees hope to meet again 
in the near future to map out 
that strategy. 
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RESEARCH 
Jefferson and SmithKline Beecham Link Clinical Research Efforts 
homas Jefferson University 
and SmithKline Beecham 
(SKB) have entered into a 
contractual relationship aimed 
to enhance the future of 
clinically based research. 
"The positive implications of 
Jefferson's agreement with 
SmithKline Beecham are 
many, and they are vast," says 
Joseph S. Gonnella, M.D., 
Senior Vice President for 
Academic Affairs and Dean. 
"Not only is there an 
immediate benefit of signif-
icant dollar amounts 
committed to Jefferson 
research efforts, but there are 
huge potential long-term 
benefits for both patients and 
physicians," says Dean 
Gonnella. 
The university's goal of 
expanding clinical trials 
activity paralleled a newly 
widened search by SKB for 
leading medical centers to 
partner with in an expanded 
program of drug development. 
"The SKB agreement marks a 
major commitment by the 
university to partnering with 
industry for drug 
development," says Gerald 
Litwack, Ph.D., Associate 
Dean for Scientific Affairs. 
The new "SmithKline 
Beecham Academic 
Partnership," which this 
leading pharmaceutical 
company invited Jefferson to 
join, currently involves 17 
academic medical centers, 
including Harvard, Duke, 
Johns Hopkins, the University 
of California, San Francisco, 
Baylor, Washington 
University, and the University 
of Pennsylvania. The program 
stresses development of 
emerging new drugs in a wide 
variety of areas. Clinical trials 
must be of very high quality, 
with time lines for completion 
comparing one university 
partner with the others to 
achieve optimum trial results. 
SKB will provide Jefferson with 
from $250,000 to one million 
dollars each year in clinical 
research grants. In addition, 
SKB will award an annual two-
year Faculty Research Grant to 
stimulate interest by younger 
physicians in clinical research. 
The first $100,000 grant is to 
David L. Fischman CD'91, 
Associate Professor of Medicine 
and Associate Director of the 
Cardiac Catheterization 
Laboratory (see article below). 
The advent of the SKB program 
neatly coincides with Jefferson's 
goal of increasing clinical 
research activity. This fiscal 
year, our activity in clinical 
research is expected to increase 
by about five million dollars. 
Many investigators at 
Jefferson already have a track 
record of very successful 
completion of clinical trials 
with SKB and other 
companies. The new SKB 
program offers the 
opportunity to broaden the 
base of these investigators at 
Jefferson. 
In addition to SKB, Jefferson 
has had a longstanding 
relationship with Merck & 
Co. Recently Rhone-Poulenc 
Rorer made a similar major 
commitment. These activities 
are conducted through 
Jefferson's new Clinical 
Research Center directed by 
Scott A. Waldman, M.D., 
Ph.D., The Samuel M. V. 
Hamilton Family Professor, 
and Robert L. Capizzi, M.D., 
The Magee Professor and 
Chairman of Medicine. 
Stents are Better than Angioplasty When Treating 
Reclosure of Vein Grafts after Coronary-Artery Bypass 
Cardiologists at Jefferson 
have found that treating 
the common reclosure of vein 
grafts in post-bypass patients 
with stents instead of 
angioplasty lowers the risk of 
death, heart attack, and the 
need for repeat bypass surgery 
or angioplasty. These findings 
may point to a new standard 
of care for the hundreds of 
thousands of patients who 
undergo coronary-artery 
bypass surgery each 
year-501,000 such 
procedures were performed in 
the United States in 1994 
alone—and later experience 
complications associated with 
the reclosure of the vein grafts  
used to construct the bypass. 
The study appeared in the 
September 11 New England 
Journal of Medicine. 
Coronary-artery bypass 
surgery uses veins from the 
leg to channel blood from the 
aorta to branches of the 
coronary arteries. increasing 
blood flow beyond the 
obstruction. "The physical 
nature of a vein graft makes it 
prone to reclosure. Within 10 
years of surgery, nearly half of 
all bypass grafts are 
obstructed setting the stage 
for recurrent angina or heart 
attack," explains principal 
investigator Michael P. 
Savage '80, Associate 
Professor of Medicine .  
Traditionally, balloon 
angioplasty had been used as 
an alternative to repeat 
surgery to reopen the vein 
grafts that clog with plaque. 
The long-term outcome of 
this procedure is poor, 
resulting in high rates of 
restenosis, heart attack and 
death. Fifty percent of 
patients treated with balloon 
angioplasty reclose within six 
months. "The poor long-term 
outcomes of angioplasty in 
these patients led us to 
investigate the use of coronary 
stents to reopen clogged vein 
grafts in our multicenter 
study," says Dr. Savage. 
The trial consisted of 220 
patients with obstructed 
bypass vein grafts randomized 
into two groups. One group 
received angioplasty to 
remove the obstruction, the 
other received Palmaz-Schatz 
stents. Six months after their 
procedure, patients 
underwent a follow-up 
angiogram. "Our follow-up 
demonstrated that the patients 
who received stents had better 
long-term clinical results," 
says Dr. Savage. "Stents had a 
greater procedural success 
continues at right 
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Two Missing Cancer-Suppressor Genes May Have Deadly Effects 
ancer geneticists at 
V./Jefferson, studying 
specially bred "knockout" 
mice, have found that two 
genes that normally protect 
against cancer may play a 
greater role than previously 
suspected in female 
development. 
In the September issue of 
Nature Genetics, Richard 
Fishel, Ph.D., and postdoctoral 
fellows Aaron Cranston, Ph.D. 
and Tina Bocker, M.D. report 
that female mice that lack a 
pair of tumor-suppressor 
genes, p53 and MSH2, stop 
growing and die a little more 
than a week after conception. 
Fishel, Professor of 
Microbiology and Immunology 
and co-discoverer of the 
human MSH2 colon cancer 
gene, thinks the answer lies 
with the X chromosome. 
Somehow, he theorizes, the 
missing genes throw off normal 
cell proliferation and 
development. He believes that 
continued from left 
rate in opening blockages 
without complications than in 
the angioplasty group. Also, 
the diameter of the stented 
vessels six months post-
procedure remained wider than 
those treated with angioplasty. 
Finally, but most importantly, 
the stented group experienced 
a 36 percent reduction in 
complications, including death, 
heart attack, and repeat bypass 
surgery and angioplasty." 
Savage believes that the results 
of the study, which led to the 
December 1996 FDA approval 
of Palmaz-Schatz stents for the 
treatment of coronary-artery 
bypass graft disease, points 
toward a new standard of care. 
by getting a better handle on 
the mechanisms by which 
these genes actually can affect 
female development, scientists 
may better understand the 
genes' roles in both normal and 
cancerous development, 
leading to important new 
therapeutic strategies. 
"The observation goes to the 
heart of how tumors develop," 
he points out. "It was 
previously found that this 
particular combination of 
altered genes is significantly 
lower in human tumors—our 
results may suggest why that is 
the case. These are two of the 
most commonly altered genes 
in colorectal cancer, and 
understanding their 
mechanism in carcinogenesis is 
crucial to the development of 
therapeutic strategies." 
When one tumor suppressor 
gene is missing, the subject 
is much more likely than 
normal to develop cancer. 
When two such genes are 
"It is exciting to know that 
stents can now offer better 
outcomes for patients whose 
long-term outlook was 
previously poor. 
David L. Fischman CD'91, 
Associate Professor of 
Medicine (see article on facing 
page), served as a co-investi-
gator on the study and 
directed the core laboratory 
responsible for the 
angiographic analysis. In 
addition to the principal 
investigators from Jefferson, 
other centers collaborating on 
the study include the Johns 
Hopkins Hospital, Yale-New 
Haven Hospital, and Beth 
Israel Hospital, Boston. 
absent or defective, the 
thinking goes, the likelihood 
of cancer development Would 
be greater still. 
P53 is the most common 
known genetic defect in human 
cancers. It may contribute to 
the development of several 
cancers, including breast, 
colon, and lung. Normally, p53 
is a kind of genetic guardian. If 
genes become damaged, p53 
shuts down everything until 
the damage can be fixed. MSH2 
is a gene that helps cells' DNA 
spell-check and repair itself 
during replication. In 1993, 
Fishel and colleague Richard 
Kolodner showed that when 
MSH2 is altered, it accounts for 
about half of all cases of geneti-
cally linked hereditary 
non-polyposis colorectal cancer 
(HNPCC)—one of the most 
common human cancer predis-
position syndromes (Fishel R et 
al., Cell, 74:1027, 1993). 
Knockout mice lack a working 
gene or genes and are used as 
models to study the effects of 
cancer gene alterations, often 
helping scientists understand 
cancer mechanisms and 
develop effective therapies. 
The researchers found that 
male knockout mice died from 
cancer at an average of 273 
days—two to three times as 
quickly as they might die with 
only one missing gene. They 
expected that. But they didn't 
expect to find that the 
combination of missing genes 
was lethal to the female mouse 
embryos. By day 9.5 of 
gestation the female mice 
stopped developing and died. 
"The embryo was undergoing 
global apoptosis, or 
programmed cell death," 
he says. "These embryos are 
self-destructing. As many as 60 
to 90 percent of the cells 
underwent apoptosis." 
During normal embryonic 
development, certain genes of 
one of the X chromosomes may 
be turned off, a process called 
X-inactivation. Normally, there 
is some damage to the X and 
other chromosomes when cells 
duplicate and go through a "cell 
cycle." Cells have an innate 
repair mechanism to fix the 
problem; both p53 and MSH2 
are involved in regulating this 
cycle as well as controlling the 
genetic repair mechanism. 
Without these two genes, the 
result is global, catastrophic cell 
death in developing females. 
One mystery that remains is the 
precise role of the two genes in 
preventing such mass cell death 
and allowing normal 
development. The p53 gene has 
been thought to have a critical 
role in apoptosis. 
Fishel sees several possibilities. 
"The interesting observation is 
that they are undergoing global 
apoptosis independent of p53," 
he notes. "Many studies suggest 
that cells that decide to 
undergo apoptosis do it in a 
p53-dependent pathway. That 
presents two intriguing 
questions: what is this p53-
independent pathway, and why 
are the cells dying? The only 
differences between males and 
females is the extra X versus Y 
chromosome. It might be that 
one of the X chromosomes is 
damaged beyond repair or that 
the Y chromosome provides 
protection," he said. "At the 
moment we favor the 'excessive 
X chromosome damage' 
argument since both MSH2 and 
p53 are involved in managing 
DNA repair." it 
23 JEFFERSON Medical College Alumni Bulletin December 1997 	 75", Year of Publication 
OBITUARIES 
Marion W. Coleman '25 died March 
7, 1996. A board certified urologist, 
he served as Chief of Urology, 
Oakland Naval Hospital during 
World War 11. He practiced in 
Dayton, OH and was on staff at 
Miami Valley, Good Samaritan, 
Kettering Memorial and Greene 
Memorial Hospitals, Dayton, OH. 
He was a Fellow of the American 
Urological Association and the 
American College of Surgeons. He is 
survived by his wife, Maria, and a 
stepson. 
William T. Hunt Jr. '27 died August 
24, 1997. A board certified ophthal-
mologist, he was on staff at Wills 
Eye, Methodist and Thomas 
Jefferson University Hospitals, 
Philadelphia, PA. He served as a 
Clinical Professor of Ophthalmology 
at Jefferson. He was a Fellow of the 
American Ophthalmologic 
Association and the College of 
Physicians of Philadelphia. He is 
survived by two daughters. 
James H. Wall '27 died June 13, 
1997. A psychiatrist, he was on staff 
at the New York Hospital, 
Westchester Division, White Plains, 
NY. A Clinical Professor of 
Psychiatry at Cornell Medical 
School, he was credited with 
improving the diagnosis and 
treatment of mental disorders and 
alcoholism in Westchester County, 
NY. From 1936-1946 he served as 
Assistant Medical Director, New 
York Hospital, Westchester 
Division, White Plains,NY, and from 
1946-1965 he served as its Medical 
Director. At the time of his death he 
resided in Freeport, ME. He is 
survived by a son. 
Robert E. McDade '29 died April 12, 
1997. He was in family practice in 
Juniata Park, PA. After retirement, 
he moved to Pennsville, NJ. He is 
survived by his wife, Lucille, and a 
son. 
Richard V. Hauver '31 died June 26, 
1997. A board certified general 
surgeon, he received the Legion of 
Merit medal for service to wounded 
soldiers during combat in World 
War II. He practiced in Hagerstown, 
MD where he was Chief of Surgery 
at Washington County Hospital. He 
was a member of Alpha Omega 
Alpha Honor Medical Society and a 
Fellow of the American College of 
Surgeons. He served as President of 
the Washington County (MD) 
Medical Society, 1945-46. He is 
survived by his wife, Thelma, and 
two daughters. 
Nathan Heiligman '33 died August 
4, 1997. He was a General 
Practitioner with a special interest 
in pulmonary diseases and practiced 
in Allentown, PA. He was on staff at 
Sacred Heart and Allentown General 
Hospitals, Allentown, PA, and 
Palmerton Hospital, Palmerton, PA. 
He is survived by two daughters and 
a son. 
William N. Eames '35 died 
December 31, 1996. He was in a 
general medical practice in Trenton, 
NJ. He held a staff appointment at 
Mercer Hospital, Trenton, NJ. He is 
survived by his wife, Grace. 
Nathan Sussman '35 died February 
25, 1996. A recognized authority on 
care and rehabilitation of the 
elderly, he was Chief of the Arthritis 
Clinic and the Department of 
Physical Medicine and 
Rehabilitation, Harrisburg Hospital, 
Harrisburg, PA, where he served 
also as President of the Medical 
Staff. He served as President of the 
Pennsylvania Academy of Physical 
Medicine and Rehabilitation, 1960-
61. He is survived by his wife, 
Hannah, a son and a daughter. 
Oscar H. Cohen '36 died February 
16, 1996. Board certified in 
radiology and nuclear medicine, he 
was a Fellow of the American 
College of Nuclear Medicine, and a 
past President of the Radiological 
Society of New Jersey. He was Chief 
of Radiology, All Souls Hospital, 
Morristown, NJ, 1951-56, and Chief 
of Radiology, Riverside Hospital, 
Boonton, NJ, 1956-75. At the time 
of his death he resided in Sun City, 
AZ. He is survived by his wife, 
Roslyn, two daughters and a son. 
Morton W. Levenson '37 died June 
8, 1997. After serving for eleven 
years as a medical officer in the 
Foreign Service of the Department 
of State, he became a General 
Practitioner in Lititz, PA. He was on 
staff at St. Joseph's Hospital, 
Lancaster, PA. He is survived by his 
wife, Rhoda, a son and a daughter. 
Gerald Krosnick '38 died September 
3, 1997. Board certified in obstetrics 
and gynecology, he practiced in 
New Haven, CT, and was on staff at 
Yale-New Haven and St. Raphael's 
Hospitals, New Haven, CT. A 
member of Alpha Omega Alpha 
Honor Medical Society, the Society 
of Sigma Xi and a Fellow of the 
American College of Obstetricians 
and Gynecologists, he was a Clinical 
Associate Professor of Obstetrics 
and Gynecology at Yale Medical 
School. He is survived by his wife, 
Helen, and a daughter. 
Victor P. Satinsky '38 died 
September 7, 1997. He was a 
Cardiovascular Surgeon on staff at 
Allegheny University 
Hospitals/Hahnemann, Philadelphia, 
PA. An innovative surgeon, he 
helped develop coronary bypass 
surgery and other medical innova-
tions, including instruments for use 
in heart surgery. Later in his career, 
he developed and directed 
educational programs for young 
people. A bachelor, he is survived 
by a brother and two sisters. 
J. Bainbridge Hanley '39 died 
August 10, 1997. He was a Flight 
Surgeon during World War II and 
was awarded two Bronze Star 
decorations. He practiced internal 
medicine, with a special interest in 
diabetes, in Bristol, CT. He held a 
staff appointment at Bristol 
Hospital, Bristol CT. He is survived 
by his wife, Frances, three sons and 
six daughters. 
Lewis Lehrer '39 died August 15, 
1997. Board certified in anesthesi-
ology, he worked at Kensington, 
Albert Einstein Medical Center and 
Philadelphia General Hospitals, 
Philadelphia, PA. From 1967-1980 
he was Chief Anesthesiologist at 
Underwood Memorial Hospital, 
Woodbury NJ. He is survived by his 
wife, Eleanor, two sons and 
daughter Luisa, Jefferson '86. 
James J. Quiney Jr. '39 died July 9, 
1997. He was in general practice in 
Bethlehem, PA. We have no further 
information at press time. 
Michael H. Lauria '40 died June 14, 
1997. He was in general practice in 
Ephrata, PA. He held staff appoint-
ments at Ephrata Community 
Hospital, Ephrata PA, Lancaster 
General Hospital, Lancaster, PA and 
Reading Medical Center and 
St Joseph's Hospital, Reading PA. He 
served as President of the Medical 
Staff and member, Board of 
Directors, Ephrata Community 
Hospital, Ephrata, PA. His wife and 
son predeceased him. 
William J. Snape '40 died 
September 21, 1997. Board certified 
in gastroenterology, he practiced in 
Camden, NJ and was on staff at 
Cooper Medical Center, Camden, 
NJ. From 1952-1980 he was Medical 
Director of the Camden County 
Psychiatric Hospital, Lakeland, NJ. 
A frequent contributor to the 
literature of his specialty, he was a 
Section Editor for the fifth edition of 
Bockus's Gastroenterology. He was a 
Fellow of the American College of 
Gastroenterology. At the time of his 
death he resided in Palos Verdes, 
CA. He is survived by a son. 
Ander M. Mumford '41 died June 
10, 1997. After 13 years in general 
practice in Winterville, NC, he took 
a residency in otorhinolaryngology 
at Duke Medical Center, Durham, 
NC. He practiced otorhinolaryn-
gology in Greenville, NC from 
1962-1982. He was on staff at Pitt 
County Memorial Hospital, 
Greenville, NC, where he served as 
Chief of Staff, 1965-1966. He is 
survived by his wife, Bedie, and a 
daughter. 
Frederick A. Robinson Jr. '41 died 
September 30, 1997. He practiced 
internal medicine in Lansdowne, 
PA. He held staff appointments at 
Delaware County Memorial 
Hospital, Drexel Hill, PA, Bryn 
Mawr Hospital, Bryn Mawr, PA, and 
Philadelphia General and 
Pennsylvania Hospitals, 
Philadelphia, PA. He is survived by 
two sons and a daughter. 
J. Robert Fox '43 died August 7, 
1997. Board certified in ophthal-
mology and otorhinolaryngology, he 
practiced in Dover, DE. He was on 
staff at Kent General Hospital, 
Dover, DE and served on the 
hospitals' Board of Directors. He was 
a Fellow of the American Academy 
of Ophthalmology and 
Otorhinolaryngology, and the 
American College of Surgeons. He is 
survived by his wife, Jane, two sons 
and a daughter. 
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Mon Q. Kwong '45 died April 25, 
1997. Board certified in 
dermatology, he practiced in Los 
Angeles, CA. He held a staff 
appointment at Hollywood 
Presbyterian Hospital, Los Angeles, 
CA., and was a Fellow of the 
American Academy of Dermatology. 
He was an Instructor in 
Dermatology at the University of 
Southern California School of 
Medicine, Los Angeles, CA. He is 
survived by his wife, Henrietta, and 
two daughters. 
Allen H. Lee '46 died July 2, 1997. 
He was in general practice in Selma, 
NC. At the time of his death he was 
Selma's sole practicing physician. He 
is survived by his wife, Claudia, a 
son and two daughters. 
John IL Helff '47 died September 
30, 1997. Board certified in 
radiology and nuclear medicine, he 
was Chairman of Radiology, 
Middlesex General Hospital, New 
Brunswick, NJ, 1952-69; Cheshire 
Hospital, Keene, NH, 1969-81; and 
Memorial Hospital, North Conway, 
NH, 1981-94. He was a member of 
Alpha Omega Alpha Honor Medical 
Society and a Fellow of the 
American College of Radiology. He 
is survived by his wife, Barbara, two 
sons and two daughters. 
Charles S. Ryan '48 died October 4, 
1997. He practiced occupational 
medicine in Valley Forge, PA., and 
was Director of Health and Safety 
for the Sun Oil Company. He also 
was Chairman of the Greater 
Delaware Valley Health Care 
Foundation and of the American 
Petroleum Institute's Epidemiology 
Research on Petrochemical 
Workers. He is survived by his wife, 
Laura, three sons and three 
daughters. 
Daniel L. ShawJr. '48 died August 
16, 1997. He was a specialist in 
clinical pharmacology and, after two 
years in the Navy, began working at 
Wyeth Laboratories, Radnor, PA. 
On retirement in 1987, he was Vice 
President of Medical Affairs at 
Wyeth Laboratories. Highly 
regarded both in the Philadelphia 
medical and corporate communities, 
he was President of the College of 
Physicians of Philadelphia 1990-92. 
He is survived by his wife, Arlene, 
two daughters and a son. 
IL Phelps Potter Jr. '49 died July 17, 
1997. Board certified in internal 
medicine, he served as Acting 
Chairman, Department of Medicine, 
Medical College of Pennsylvania, 
Philadelphia, PA, 1961-69. He then 
moved to Paoli Memorial Hospital, 
Paoli, PA where he served as Chair 
of the Department of Medicine, 
Chief of the Gastrointestinal 
Section, and president of the 
Medical Staff. He was a member of 
Alpha Omega Alpha Honor Medical 
Society and a Fellow of the 
American College of Physicians. He 
is survived by his wife, Beverly, and 
two daughters. 
Robert W. McLaughlin '51 died 
March 20, 1997. He practiced 
general medicine, obstetrics and 
anesthesiology in Penn Yan, NY. He 
was on staff at Soldiers and Sailors 
Hospital, Penn Yan, NY. He was 
twice President of the Geneva (NY) 
County Medical Society. He is 
survived by his wife, Joan, a 
daughter and three sons. Son Scott 
is Jefferson '95. 
Robert B. Cahan '54 died July 29, 
1997. Board certified in both 
neurology and psychiatry, he 
practiced general and forensic 
psychiatry in San Francisco, CA. A 
Fellow of the American Psychiatric 
Association, he served as a Clinical 
Associate Professor of Psychiatry, 
University of California, San 
Francisco. He is survived by his 
wife, Bernice, and a son. 
Carl W. Hassler '62 died June 19, 
1997. He was in family practice in 
Reading, PA. He held a staff 
appointment at Reading Hospital 
and Medical Center, Reading, PA. A 
former star football player, he 
served as team physician for the 
football team of Wilson High 
School, Reading PA. He is survived 
by his wife, Elizabeth, and two 
daughters. 
Jack W.P. Love Jr. '62 died October 
25, 1997. Originally in general 
practice in Woodbury, NJ, he later 
switched to emergency medicine 
and became board certified. He was 
appointed Chief of Emergency 
Medicine, Underwood Memorial 
Hospital, Woodbury, NJ in 1974. 
During his long and productive 
tenure at Underwood Memorial 
Hospital, he served as President of 
the Medical Staff and a member of 
the hospital's Board of Trustees. He 
is survived by his wife, Sally, three 
sons and two daughters. Son 
Thomas is Jefferson 2000. 
Laurence R. LeWinn '66 died July 
17, 1997. Board certified in plastic 
and reconstructive surgery, he 
practiced in Palm Desert, CA. He 
was Chief of Plastic Surgery at the 
Eisenhower Medical Center, Rancho 
Mirage, CA. He is survived by his 
wife, Maja, a son and a daughter. 
John P. Manges Jr. '68 died June 1, 
1997. Board certified in internal 
medicine, he served in the United 
States Public Health Service on the 
Wind River Reservation in 
Wyoming, and as a member of the 
Indian Health Service in Santa Fe, 
NM. He then practiced general and 
addiction medicine in St. Johnsbury, 
VT. He held a staff appointment at 
Northeastern Vermont Regional 
Hospital, St. Johnsbury, VT. He 
served for several years as President 
of the Society for Re-Introduction of 
Values into New England. In 
February 1997, he relocated to 
Boulder, CO to work as an internist 
with Kaiser Permanente. He is 
survived by his wife, Jeanne, and 
two sons. 
Donna Price '83 died April 21, 
1997. Board certified in otolaryn-
gology, she practiced in Syracuse, 
NY. She was a Clinical Professor of 
Otolaryngology, State University of 
New York at Syracuse. She is 
survived by her parents. 
K. Kalman Faber PD'49 died 
October 20, 1997. Charismatic, 
enthusiastic, and courageous, 
"Kuddie" Faber became Jefferson's 
first pediatric resident in 1947. In 
the book Thomas Jefferson 
University: Tradition and Heritage, 
he is described as the doctor whose 
growth virtually paralleled the 
development of the Department of 
Pediatrics into a modern pediatric 
facility, and the man who was 
elected by acclamation chairman of 
the board of Doc Watson's Pub 
across the street from the medical 
college. He lived and practiced 
pediatrics with gusto, and clearly 
was Jefferson's most popular 
pediatrician as evidenced by the 
number of his colleagues' families, 
students, nurses, and hospital 
employees who became his patients. 
He was a Clinical Associate 
Professor of Pediatrics, and was in 
private practice for 50 years. In 
1993 Jefferson recognized his 
lifetime contributions to pediatrics 
and to Jefferson by awarding him 
the Leon A. Peris Memorial Award, 
given to a member of the volunteer 
faculty for excellence in clinical 
teaching and superior patient care. 
He is survived by his wife, Elaine, 
two sons, and two daughters. 
Staff 
Jack R. Schott died July 27 at age 59. 
He was the husband of Joan E. 
Schott, a 36-year employee in the 
JMC Alumni Office (currently 
Associate Director of Annual 
Giving). Jack Schott was one of the 
Philadelphia Flyers' earliest and 
most loyal fans, and President of the 
Flyers Fan Club from 1985 to 1992. 
He was a dispatcher for Core 
Trucking Company in Bensalem. 
Our thoughts are with Joan and 
their son Kenneth. 
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Can You Host a Student 
Interviewing in Your Area? 
Students will be contacting alumni during November, December, and January requesting housing while they are 
interviewing for residencies. Alumni have found that this is a 
fun way to catch up on what's happening at Jeff, and to meet 
physicians-to-be who may soon be practicing in their region. 
If you would be willing to host a student interviewing in your 
area, please return the form below to JMC Alumni Office, 
1020 Locust Street M-41, Philadelphia, PA 19107. 
Name 
	
 Class Year or Jeff Affiliation 
Mailing Address 	  
State 	  Zip 	  
Daytime Phone 
	  
I would be willing to host a student interviewing in my area. 
City 
Statement of Ownership, Management, and Circulation (PS Form 3526) 
(required by 39 U.S.C. 3685, United States Postal Service) 
1. Publication title: Jefferson Medical College Alumni Bulletin 
2. Publication number: 00215821 
3. Date of filing: 9/97 
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5. Number of issues published annually: four 
7. Complete mailing address of office of publication: 
Suite M-41, 1020 Locust Street, Philadelphia, PA 19107 
8. Mailing address of general business office of publisher: same as above 
9. Publisher: Jefferson Medical College of Thomas Jefferson University (address above) 
Editor: Mary B. Monteith (address above) 
Managing Editor: Malcolm Clendenin (address above) 
10. Owner: Jefferson Medical College of Thomas Jefferson University (address above) 
11. Bondholders, mortgagees, and other security holders owning or holding one percent 
or more of total amount of bonds, mortgages, or other securities: none 
12. For nonprofit organizations authorized to mail at special rates: 
the purpose, function, and nonprofit status of the organization, and the exempt status 
for Federal income tax purposes have not changed during the preceding 12 months 
15. Extent and nature of circulation 	 Average Number Copies 
of Each Issue During 
Preceding 12 Months 
Actual Number Copies 
of Single Issue Publishec 
Nearest to Filing Date 
A. Total number of copies (net press run) 18,500 18,500 
B. 	 Paid and/or requested circulation 
1. Sales through dealers, carriers, 
street vendors, counter sales 0 0 
2. Paid and/or requested mail subscriptions 17,900 17,900 
C. Total paid and/or requested circulation 17,900 17,900 
D. Free distribution by mail 290 290 
E. 	 Free distribution outside the mail 300 300 
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CLASS NOTES 
'27 
Samuel M. Dodek of Chevy Chase, 
MD was presented with a Certificate 
of Recognition in appreciation of his 
dedication and service to the 
Department of Obstetrics and 
Gynecology by the George 
Washington University School of 
Medicine, where he serves as an 
Emeritus Professor. 
'41 
Louis C. Blaum Sr. of Bear Creek 
Township, PA has retired from 
medicine and he and his wife, 
Kathleen, reside in Florida. Their 
son Louis C. Blaum Jr. '72 of 
Kingston Township, PA specializes 
in thoracic and breast surgery. He is 
on staff at Wyoming Valley 
Hospital. The third generation is 
Louis "Louie" C. Blaum III '97 of 
New Brunswick, NJ who plans to 
practice plastic and reconstructive 
surgery. All three were members of 
the same fraternity. They lived in 
the same room at Alpha Sigma, 
which became famous as "The 
Blaum Room." The Blaums all agree 
with Dr. Blaum Jr. who says, "There 
is nothing better than to have been 
given the privilege to be a part of a 
patient's life and to make their life 
better." 
Co-authors of Thomas Jefferson 
University: Legend and Lore, 
Frederick B. WagnerJr. '41, The 
Grace Revere Osler Professor 
Emeritus of Surgery and University 
Historian, and J. Woodrow Savacool 
'38, Honorary Clinical Associate 
Professor of Medicine, received 
praise in the January 15, 1997 
Journal of the American Medical 
Association. Dr. Howard Spiro of 
Yale University School of Medicine 
applauded the editors' efforts "in 
finding old pictures and other 
details that embellish every article" 
and encouraged anyone "curious 
about the ways of doctors" to read 
the book. It's available through the 
Jefferson Bookstore, (215) 955 
7922. 
Herbert A. Luscombe, who from 
1959 to 1986 chaired the 
Dermatology Department, has now 
fully retired from practice. 
'45 
Stephen F. Balshi of Bethlehem, PA 
is still working part-time as an 
otolaryngologist, as well as traveling 
extensively. 
'46 
David G. Simms of Huntington 
Beach, CA was made an honorary 
member of the German Association 
for Orthopaedic Sports Injury after he 
gave an invited presentation on 
"Advances in Our Understanding of 
Myofascial Trigger Points" in June 
1997. 
'47 
Gerald D. Dodd of Houston, TX has 
been awarded the Mucio Athayde 
Cancer Prize by the International 
Union Against Cancer for his contri-
butions to breast cancer diagnosis 
(see his article in this issue). Dr. 
Dodd was among those who 
developed modern-day mammog-
raphy for the diagnosis of breast 
cancer in women. He was presented 
the award at the organization's first 
Cancer Management Meeting in 
Vienna. 
'52 
John M. McGehee of Mobile, AL was 
recognized for his service to internal 
medicine and awarded the Alabama 
Chapter Laureate Award presented by 
the American College of Physicians. 
Herbert C. Mansmann Jr. '51, 
Professor of Pediatrics, is 
inducted into the Honor Roll 
of the Philadelphia Pediatric 
Society, upon the occasion of 
the society's 100th anniversary. 
Here he receives his award 
from Gary A. Emmett '76, 
Director of General Pediatrics 
at Jefferson, who was 
Treasurer of the society. 
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Goldstein Appointed Vice President for 
Research at Juvenile Diabetes Foundation 
'58 40th Reunion June 6 
Since retiring, James M. LaBraico of 
Charlestown, RI, has been doing 
consulting work to the pharmaceu-
tical industry. He is an active 
volunteer at the Boston Museum of 
Science and recently elected to the 
Board of Directors of its Volunteer 
Service League. 
'59 
Herbert J. Somers and his favorite 
working partner, his daughter Debra 
Lynne Somers '89, are both 
obstetrician/gynecologists. The 
Somers father-and-daughter team, 
along with two other physicians in 
the practice, work out of three 
offices. They are part of the Temple 
Physician Network, which is affiliated 
with Temple University Hospital. 
'60 
Charles W. Balaicuis of Johnson 
City, TN recently opened his office in 
Elizabethton, TN for the practice of 
Child Psychiatry and Habit 
Disorders. He had a daily worldwide 
radio program for 10 years. 
'61 
Jack Krauss of Merion Station, PA 
has been appointed Instructor of 
Psychiatry and Human Behavior at 
Jefferson. 
>64 
James J. Houser of Franklin, PA was 
honored by the Pennsylvania Chapter 
of the American College of Physicians 
with the prestigious Laureate Award 
for his "abiding commitment to 
excellence." 
'70 
Harvey B. Lefton of Huntingdon 
Valley, PA is President-Elect of the 
Frankford Hospital Medical Staff and 
Head of the Section of 
Gastroenterology. 
Norman G. Loberant of Nahariyn, 
Israel, Director of the Radiology 
Department at Western Galilee 
Hospital in Nahariyn, spoke on his 
study of the ductus venosus in 
premature infants at the 1997 
Meeting of the Israel Ultrasound 
Society. Special guest speaker at this 
meeting was Laurence Needleman 
R'83, Associate Professor of 
Radiology at Jefferson. Dr. 
Needleman delivered the 15th 
Robert A. Goldstein, M.D.'66, Ph.D., 
M.B.A. has been 
appointed Vice President 
for Research of the 
Juvenile Diabetes 
Foundation International 
(JDFI). Dr. Goldstein will 
work out of both New 
York City and Washington, D.C. 
and will be responsible for the 
world's largest private, nonprofit 
program in diabetes research. In 
addition, a major responsibility over 
the next months will be to continue 
the work of JDFI's Research Task 
Force (which Dr. Goldstein has 
been co-chairing) and to develop 
the Task Force's final reports and 
the plans and programs to 
implement its recommendations. 
In a typical year JDFI provides over 
$30 million to basic and clinical 
research for a cure for diabetes and 
the ability to prevent the disease and 
its complications. A wide variety of 
research programs are being 
supported through funds provided 
by the donations of individuals, 
foundations, and corporations. 
These include hundreds of investi-
gator-initiated research grants, 
career development awards, and 
postdoctoral fellowships and 26 
Annual Barry B. Goldberg Lecture 
(named for a Jefferson faculty 
member) along with additional talks 
on various topics in Doppler 
sonography. Dr. Loberant's daughter 
Leslie will graduate from Jefferson 
Medical College this June. 
'74 
James D. Plumb of Doylestown, PA, 
who is a Clinical Associate Professor 
Diabetes Interdisciplinary 
Research Programs 
throughout the world. 
Dr. Goldstein is a 
physician, clinician-
investigator, basic 
scientist, and research 
administrator with 
several years of 
experience as a senior administrator 
at the National Institutes of Health. 
Dr. Goldstein completed his 
internship in internal medicine at 
Philadelphia General Hospital, and a 
residency in internal medicine and 
fellowship in pulmonary disease at 
the Veterans Administration 
Medical Center in Washington, D.C. 
He earned a Ph.D. in 
microbiology/immunology at 
George Washington University, and 
subsequently served as Acting 
Director of the Pulmonary Disease 
Division of George Washington 
University Medical Center. 
In 1978, Dr. Goldstein joined the 
National Institute of Allergy and 
Infectious Disease (NIAID) and 
served successively for a decade as 
Chief of Allergy and Clinical 
Immunology and then Chief of 
Clinical Immunology and 
Immunopathology. 
of Family Medicine and Associate 
Medical Director of the Jefferson 
Hospice, was awarded the 
Pennsylvania Bar Association's 
Liberty Bell Award. It is given 
annually to a Pennsylvanian who is 
neither a lawyer nor a judge and has 
demonstrated a commitment to 
community service. Dr. Plumb 
received the award for his efforts as 
the faculty advisor for JeffHOPE, the 
student-run, four-site medical clinic 
In 1988, Dr. Goldstein became 
Director of the Division of Allergy, 
Immunology, and Transplantation, 
one of the three extramural 
divisions of the NIAID. His respon-
sibilities in this position included 
management of a research portfolio 
of over 1000 grants, contracts, and 
fellowships amounting to approxi-
mately $216 million in fiscal year 
1997. In addition, he was respon-
sible for relating NIAID not only to 
other NIH institutes, but also to 
other governmental agencies such 
as the Veterans Administration and 
the Food and Drug Administration, 
to the pharmaceutical and biotech-
nology industries, and to a variety 
of private nonprofit constituency-
based volunteer organizations. He 
has also been serving as Director 
of the World Health Organization's 
Collaborating Centre for Allergic 
Diseases at NIAID. 
In 1992, Dr. Goldstein received a 
M.B.A. degree from New York 
University's Stern School of 
Business. 
Dr. Goldstein has published 
numerous journal articles relating 
to cell-mediated immunity and 
pulmonary diseases and has served 
as a reviewer for the Annals of 
Internal Medicine and the New 
England Journal of Medicine. 
for homeless and underserved 
Philadelphians. 
'75 
Irwin S. Goldstein of Bala Cynwyd, 
PA has been appointed an Instructor 
of Dermatology and Cutaneous 
Biology at Jefferson. 
Janine A. Matsho of Philadelphia 
was recently promoted to Attending 
Surgeon on the Cataract and 
Primary Care Services at Wills Eye 
Hospital. She serves as President of 
the Ophthalmologic Club of 
Philadelphia. 
'76 
Kurtis D. Jens of Lancaster, PA and 
David E. Nutter '76 have recently 
formed Mid-Atlantic Psychiatric 
Physicians in Lancaster. Dr. Jens has 
been installed as President of the 
Lancaster City and County Medical 
Society. 
Read the Bulletin on the Net 
This magazine is available on-line at 
http://jeffline.tju.edu/CWIS/JMC/alumni/bulletin.html 
The electronic version includes all the photos and graphics 
as well as text. Back issues are there too. Explore the options 
within the Reader available on the World Wide Web site—
including zoomable photos and topic-search capability. 
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Abbott Labs 
American Int'l Group 
Archer-Daniels-Midland 
Boeing Co. 
Campbell Soup 
Coca-Cola 
Compaq 
Disney 
Gillette 
Hewlett-Packard 
Intel 
IBM 
Johnson & Johnson 
Lucent Technologies 
Play Your 
JEFFERSON-BLUE Chips 
Right 
McDonald's' Corp. 
Microsoft 
Motorola 
Oracle 
Procter & Gamble 
Sherwin-Williams 
or other appreciated stocks 
If so, you can increase your income by making a gift of your appreciated shares to a Jefferson Life Income Fund. 
Historically, these (and many other stocks) have been excellent long-term investments. However, they all currently pay 
less than two percent annually. By making a gift of appreciated stocks to Jefferson, rather than selling them, you can achieve: 
/A significant increase in your income 	 /Diversification of your portfolio 
/An immediate income tax deduction 	 /Free gift management by Jefferson 
/Freedom from capital gains liability 	 /The satisfaction of investing in Jefferson's future 
For more information on Jefferson's life income arrangements, please contact 
Frederick "Fritz" Ruccius 
Director of Development for Planned Giving 
834 Chestnut Street, Suite 314 
Philadelphia, PA 19107-5127 
215-955-7990 Fax 215-923-5164 
email: frederick.ruccius@mail.tju.edu 
Do you own stock in any of these companies? 
'78 20th Reunion June 6 
Rudolph M. Krafft of Cortland, OH 
is the new Associate Director of the 
Family Practice Residency Program 
at St. Elizabeth Health Center in 
Youngstown, OH. 
Paul E. Pilgram of Salt Lake City, 
UT and wife, Christine joyfully 
announce the birth of triplets. The 
two boys and one girl were born 
December 13, 1996 and are finally 
home after their five-month stay in 
the hospital. The triplets are doing 
extremely well. 
David H. Trump of Clifton, VA, a 
Captain in the U.S. Navy, is 
currently Director, Military Public 
Health in the Office of the Assistant 
Secretary of Defense for Health 
Affairs. 
'80 
Donna P. Carr of Leucadia, CA has 
retired from her private practice of 
internal medicine due to pulmonary 
and orthopaedic problems. She is 
presently at home caring for her 
eight-year-old daughter and five-
year-old son. She and her husband, 
Ken, recently visited Gary Dukart 
'80 in California, and had a family 
dinner with Marianne T. Ritchie '80 
and her husband, Stuart L. Gordon 
'81, and James A. Wilson '80 in 
New Jersey. 
Joseph M. Devlin and his wife, 
Anita, of York, PA proudly 
announce the birth of Madelyn 
Regina, born June 3, 1997. 
John A. Friedline of Royal Oaks, MI 
has switched specialties from family 
medicine to pathology, having just 
completed his residency in anatomic 
and clinical pathology at West 
Virginia University. Dr. Friedline 
has started his fellowship in 
hematopathology at the William 
Beaumont Hospital in Royal 
Oaks, MI. 
'83 15th Reunion June 6 
Louis F. D'Amelio of Belle Mead, NJ 
was recently promoted to Associate 
Professor, Section of Trauma and 
Surgical Critical Care, UMDNJ-
Robert Wood Johnson Medical 
School in New Brunswick. A good 
friend and classmate of his, John P. 
Sutyak '83, is a member of the same 
department as Louis; they have both 
achieved this milestone at the same 
time. Dr. D'Amelio states, "Many of 
our best residents are Jeff 
graduates." 
Timothy M. Heilmann and wife, 
Sue, of Williamsport, PA welcomed 
their seventh child, Jennifer, in 
April of 1997. Dr. Heilmann is 
currently an Associate Director of 
the Williamsport Hospital Family 
Practice Residency Program. 
'88 10th Reunion June 6 
Scott E. Olitsky of Buffalo, NY have 
been named Program Director of the 
Residency Program in 
Ophthalmology at The State 
University of New York at Buffalo 
where he is Assistant Professor in 
the division of Pediatric 
Ophthalmology. 
'89 
Herbert C. Conaway Jr. of 
Burlington, NJ served as a Captain 
in the Air Force medical corps 
from 1992 to 1996. He also earned 
The Alumni at a Glance 
/Total number of graduates living and deceased since the 
founding of Jefferson Medical College: 27,405 
/Number of living alumni: 9,731 
/Total number of postgraduate alumni living and deceased: 
3,090 
/Total number of living postgraduate alumni: 3,008 
/Total number of Jefferson Medical College graduates 
who did part or all of their training at Jefferson: 1,397 
/Total number of living Jefferson Medical College graduates 
who did part or all of their training at Jefferson: 1,347 
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Dr. Brezinki (left) with Prof. Fujimoto (right) 
and members of their research team 
YOUNG INVESTIGATOR 
Brezinski Develops Noninvasive Method to 
Detect Early Signs of Cancer and Heart Attacks 
esearchers at Massachusetts 
eneral Hospital led by 
Mark E. Brezinski '88, in 
conjunction with scientists at 
the Massachusetts Institute of 
Technology, have developed a 
noninvasive method of 
detecting early signs of cancer 
and heart attacks, which they 
reported in Science magazine, 
June 27, 1997. 
The new method is known as 
optical coherence tomography 
(OCT). OCT produces a clear 
picture of a cross-section of 
bodily tissue without requiring 
surgical biopsy. Using laser 
light, OCT can magnify tissue 
to allow visualization of 
individual cells without 
damaging the tissue. 
OCT is based on optical fiber 
technology, the same 
technology now used in 
telecommunications. An optical 
fiber is a string-like component 
which guides light waves, 
allowing a light beam to be 
controlled over long distances 
and around bends. 
OCT can be compared to 
ultrasound, except that infrared 
light waves are used rather than 
acoustic waves. Ultrasound 
sends out waves of sound and 
interprets the echoes reflected 
back by structures to create a 
visual image. A ship's sonar, for 
example, reveals the ragged 
terrain of the ocean far below 
it. Similarly, OCT shines a 
beam of infrared light into 
tissue structure, and its back-
reflections, measured from 
different positions, form an 
image of the terrain within. 
Thanks to OCT's high 
resolution-10 times higher 
than either clinical MRI or high 
frequency ultrasound— 
microscopic early signs of 
disruption in tissue terrain can 
be detected and treated. 
The infrared light used in OCT 
is introduced to tissue by 
means of a small catheter, or 
endoscope, which can be used 
virtually anywhere in the body. 
Dr. Brezinski, one of the two 
principal investigators, is a 
cardiologist at Massachusetts 
General Hospital, an Assistant 
Professor at Harvard Medical 
School, and a Research Affiliate 
in Electrical Engineering and 
Computer Science at MIT. Co-
principal investigator is James 
G. Fujimoto, Ph.D., Professor 
in Electrical Engineering and 
Computer Science at MIT. 
The program for developing 
OCT had two stages, the first 
of which involved imaging of 
transparent tissue. This began 
in 1991. OCT imaging of the 
retina provides a "very powerful 
tool for ophthalmic diagnostics, 
especially for conditions such as 
glaucoma and macular edema," 
says Professor Fujimoto. To 
date, several thousand patients 
have been examined using 
OCT. The results suggest OCT 
may be a promising way to 
diagnose early-stage glaucoma. 
In 1994, in a collaboration led 
by Professor Fujimoto and Dr. 
Brezinski, OCT imaging was 
developed for optical biopsy in 
nontransparent tissue which 
represents most of the tissue 
of the body. 
The key advance described in 
the article in Science is the 
demonstration of OCT for 
imaging nontransparent tissue 
in vivo. In the article, the 
researchers used OCT to image 
the esophagus of a living rabbit. 
"This advance opens up the 
possibility of an incredibly 
broad range of clinical applica-
tions," adds Prof. Fujimoto. 
Developing OCT to its current 
status required persistence and 
an effective collaboration 
among researchers. "Three and 
one-half years ago, I was told by 
many people that this project 
wouldn't work, that light 
wouldn't penetrate deeply 
enough. Now we are just about 
ready to test OCT in patients 
through a high-speed, high-
resolution catheter/ 
endoscope-based system," says 
Dr. Brezinski. 
"This could not have been 
accomplished by one or two 
individuals but represented the 
vertical integration of students, 
postdoctoral fellows, and investi-
gators, a fact of which we are all 
very proud. If you compare this 
to other technologies like 
ultrasound and MRI, we have 
come a tremendous way in three 
and one-half years." 
The researchers suggest that 
OCT will replace conventional 
biopsy for many applications in 
the future. First, OCT can be 
used where conventional biopsy 
would be hazardous, the brain 
and coronary arteries being the 
most prominent examples. 
Second, OCT could serve well 
where surgical biopsy misses the 
diagnosis, such as in early cancer 
detection in the colon, 
esophagus, and cervix. Third, 
they suggest OCT can be used to 
guide surgical and microsurgical 
procedures such as nerve repair 
or prostate surgery. 
Now, Brezinksi and colleagues 
are working directly with 
patients, increasing the 
resolution to allow OCT to be 
applied to early diagnosis of such 
disorders as cervical cancer, and 
exploring technologies to use 
with OCT, such as spectroscopy, 
which may allow biochemical as 
well as structural information to 
be gained from tissue. 
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CLASS NOTES 
his J.D. during those same years 
from Rutgers Law School in 
Camden and is now doing a 
residency in internal medicine at 
Cooper Hospital/University Medical 
Center. Dr. Conaway recently 
married Kathleen Heintz and has a 
wonderful two-year-old daughter, 
Alexandria. 
David W. Dinwiddie and his wife, 
Maria Alaimo-Dinwiddie '90, of 
Encino, CA proudly announce the 
birth of their second child, Gina 
Rose, born August 23, 1997. Their 
first child, David Sal, is four years 
old and very happy to be a big 
brother. 
'90 
P. Kurt Bamberger of Silver Spring, 
MD received the General Graves B. 
Erskine Award as an outstanding 
graduating general surgery resident. 
His mentors wrote, "Dr. Bamberger 
has excelled in the clinical care of 
the most complex patients. He is 
Whitcomb Active "Hospitalise" 
V\ts inthrop F. Whitcomb '89 is co-founder of the 
National Association of 
Inpatient Physicians, which 
has a data base on "over 1,000 
hospitalists." Dr. Whitcomb is 
also Course Director for the 
association's first annual 
meeting to be held April 1, 
1998 in San Diego. He is 
Medical Director of the Mercy 
Internal Medicine Service at 
Mercy Hospital, a 200-bed 
community hospital in 
Springfield, Massachusetts. 
This service is fairly typical of 
the hospitalist concept. He 
explains, "It provides 
inpatient medical care for 
patients referred from outside 
physicians or those without 
physicians. Additionally, the 
service admits all internal 
medicine cases and handles all 
floor emergencies between 11 
P.M. and seven A.M., allowing 
the on-call community 
Sinai Medical Center, New York City, 
Division of General Internal Medicine. 
Michael E. Lekawa of Tustin, CA 
completed his fellowship in surgical 
critical care at UC Irvine. He is now 
an Assistant Professor of Surgery 
there, and Director of Trauma and 
Critical Care. He and his wife, Sajee, 
have a three-year-old daughter named 
Serena. 
'91 
Wayne B. Bauerle of Myrtle Beach, 
NC has joined the orthopaedic 
surgery department at Grand Strand 
Regional Medical Center. 
Melanie S. Kelton-Landau of New 
York, NY and husband David are 
was born May 1, 1997. Melanie is 
currently on the faculty of the Mt. 
thrilled to announce the birth of 
their first child. Andrew Benjamin 
	
Stanley C. Marczyk of Cranberry 
Township, PA has completed his 
fellowship in hand and upper 
extremity surgery at Allegheny 
General Hospital in Pittsburgh. He is 
entering into private practice in South 
Please submit news for Class Notes to: 
Attention: Alumni Bulletin 
Jefferson Medical College of Thomas Jefferson University 
1020 Locust Street, Suite M-41 
Philadelphia, PA 19107-6799 
Fax: 215 923 9916 Attention: Alumni Bulletin 
E-mail: Malcolm.Clendenin@mail.tju.edu 
World Wide Web site: 
http://jeffline.tju.edu/CWIS/JMC/alumnilbulletin.html 
Would you like to contact the Alumni Office electronically? 
Send information such as address changes or personal and 
professional changes to: jmcalums@jeflin.tju.edu 
ta,  
Readers are encouraged to submit nominations for: 
1) Alumni Trustee of Thomas Jefferson University: One is 
elected each year for a three-year term (he or she may be 
reelected for one additional term). Please submit names of 
worthy candidates to "Attention: Alumni Trustee Committee," 
1020 Locust Street, Suite M-41, Philadelphia, PA 19107. 
2) Alumni Achievement Award: Although the award carries 
no monetary stipend, each recipient's name is permanently 
affixed to a plaque prominently displayed at the entrance to 
Jefferson Alumni Hall. The recipient is presented with a 
handsome silver tray, suitably engraved and bearing the seal 
of the medical college, as the highlight of the Alumni Banquet 
each June. The Achievement Award Committee of the Alumni 
Association is charged with the final selection; the committee's 
decisions are not subject to review. Please direct curricula 
vitae and bibliographies of alumni whose professional 
activities are sufficiently outstanding to warrant consideration 
to "Attention: Achievement Award Committee," 
1020 Locust Street, Suite M-41, Philadelphia, PA 19107. 
Bermuda in June 1998 
As part of their 50th Reunion celebration the Class of '48 is 
going to Bermuda June 7-11, 1998. They cordially invite other 
Jefferson alumni and friends to go with them. 
For information and reservations kindly contact: 
Gail Pensabene (Travel Agent) 
Spring House Travel Village Center 
Spring House, PA 19477 
Phone: 215-643-7074 Fax: 215-643-6737 
A $300 deposit is required by January 31 to hold a seat. 
It will be a wonderful trip! Hope you can come. 
internists to sleep at night. 
Currently our 'hospitalise group 
employs six physicians full-time 
and several part-time. The first 
challenge in establishing the 
service was to gain acceptance 
by the hospital's medical staff 
of community practitioners. 
"The concept responds to the 
need to maximize efficiency of 
medical care. It eliminates the 
time formerly spent by 
outpatient physicians 
commuting to and from the 
hospital. Instead, the hospitalist 
is always on site. Most 
hospitalists are salaried 
employees of an HMO or 
hospital, but some work as 
their own practice in a fee-for-
service model." 
The "hospitalist" concept was 
succinctly described by 
Wachter and Goldman in the 
New England Journal of 
Medicine, August 15, 1996, at 
page 514. 
widely respected throughout the 
Department of Surgery for his mature 
judgment and devotion to all details 
of the management of patients." 
Jeffrey M. Hoffman of Boca Raton, FL 
recently married and is a member of 
the medical staff of St. Mary's 
Hospital, Pediatric Emergency 
Department, in West Palm Beach, FL. 
30 	 JEFFERSON Medical College Alumni Bulletin 	 December 1997 	 75 0, Year of Publication 
Jersey with Atlantic Shore 
Orthopaedic Associates. He and his 
wife, Mara, proudly announce the 
birth of their second son, Matthew 
Ryan, born March 18, 1997. Their 
oldest son, Stanley (Stash) Patrick, 
is two and one-half. 
Lawrence C. Rosenbaum of Aptos, 
CA is practicing internal medicine 
in Santa Cruz, CA. He and his wife, 
Amy, are enjoying life with their 
son, Zachary Isaac, born July 2, 
1996. 
'92 
David L. Carter of Elizabeth City, 
NC is one of the newest members of 
the Carolina Surgical Care team 
working out of Gates County 
Medical Center. He and two others 
are responsible for general, thoracic, 
and vascular surgery in the 
Elizabeth City and Kitty Hawk 
offices. 
Scot R. McKenna of Philadelphia, 
PA completed a five-year general 
surgery residency at Mercy Hospital 
of Pittsburgh. He finished as chief 
resident in June and was the 
recipient of the Albert G. 
Marrangoni, M.D. Surgical Research 
Award. While at Mercy Hospital, 
Berger Studies 
Prion Disease 
oseph R. Berger '74 
) received considerable media 
attention in September for his 
observation on a possible 
relationship between 
Creutzfeldt-Jakob disease (a 
prion disease in humans that is 
similar to "mad cow" disease) 
and eating squirrel brains, a 
not uncommon food in 
Kentucky. Dr. Berger is 
Professor and Chairman of 
Neurology at the University of 
Kentucky College of Medicine. 
In the August 30 issue of Lancet, 
Dr. Berger was the first of three 
authors on "Creutzfeldt-Jakob 
Disease and Eating Squirrel 
Brains." The discovery made 
the pages of Newsweek and the 
Associated Press. 
Dr. McKenna participated in multiple 
research projects and presented his 
work on burn treatment at confer-
ences in the United States, Argentina, 
and Colombia. He has begun a plastic 
surgery residency at Temple 
University Hospital. 
Prion diseases spread through 
the ingestion of infected 
tissue. Mad cow disease seems 
to have spread through British 
herds when cattle were fed 
protein supplements made 
from the ground-up body 
parts of other cattle that 
were infected. 
As for the possible danger of 
infected squirrels, not only the 
brain but any part of a diseased 
animal could theoretically 
transmit a prion condition 
to a human who ate it. 
Dr. Berger notes that the 
study is still preliminary; 
the researchers are currently 
increasing their epidemiologic 
survey. 
'93 Fifth Reunion June 6 
Eric R. Mariotti and his wife, Deb, 
of Louisville, KY proudly 
announce the birth of David 
Matthew, born June 18, 1997. Dr. 
Mariotti is doing a fellowship in 
plastic and reconstructive surgery. 
Antonio J. Ripepi of Cleveland 
Heights, OH has begun a 
fellowship 
in minimally invasive surgery at 
the Cleveland Clinic. 
John T. Tong of Los Angeles, CA 
has completed his residency at the 
Jules Stein Eye Institute in Los 
Angeles and will specialize in 
pediatric ophthalmology. This is a 
fine tribute to Leonard Apt '45 
who is a mentor for Dr. Tong. 
'94 
Jeffrey G. Adams of Quincy, MA 
and his wife, Kimberly, proudly 
announce the birth of their first 
child, Brea, born July 10, 1997. 
Carole D. Levy and her husband, 
David, of Wallingford, PA proudly 
announce the birth of a baby boy, 
Jacob Benjamin. 
Holli S. Pheasant of Lansdowne, 
PA married John Viscusi Jr. in May 
1997. 
Daniel S. Rifkin of Merion, PA is a 
fellow in pediatric pulmonology at 
St. Christopher's Hospital for 
Children. 
'95 
Susheel P. Patil of Shaker Heights, 
OH will become Chief Resident in 
internal medicine at the University 
of Cleveland. He plans to specialize 
in pulmonary/critical care medicine. 
Paul R. Stauffer, a second-year 
surgical resident from York, PA, 
was part of the York Medical 
Mission which traveled to the 
poorest part of India, Chamba, in 
the foothills of the Himalayas. This 
was Dr. Stauffer's third trip. He 
spent one year there studying the 
Hindi language, among other 
things. 
A United Nations' organization, 
Impact India, had arranged for 
patients to gather in Chamba. Many 
had traveled for days just to be 
treated by one of the health profes-
sionals. 
The medical team was made up 
of nurses, an anesthesiologist, and 
eight doctors, including a plastic 
surgeon, a gynecologist, and an ear, 
nose, and throat specialist. The 
team had to bring much of their 
own supplies. 
'96 
Andrew Kwak and his wife, Gina, of 
Wynnewood, PA joyfully announce 
the birth of their daughter, Kyra 
Lee, on June 14, 1997. Andrew is a 
first-year radiology resident at 
Jefferson. 
'97 
JenniferJo Dischel of Ashland, MA 
is an Air Force captain, and was the 
only doctor on Air Force Two when 
it carried Vice President Al Gore to 
a day-long visit in Boston. Jennifer 
is serving an internship as a flight 
surgeon at Andrews Air Force Base, 
MD, where Air Force One and Two 
are based. 
Postgraduate Alumni 
Marc L. Schwartz IM'81 of 
Philadelphia was elected President 
of the Medical Staff at Jefferson for 
the July 1997 through June 1999 
term. 
Anne Marie C. Angeles D'91 of 
Merion, PA has been appointed 
Instructor in Dermatology and 
Cutaneous Biology at Jeff. 
ToddJ. Albert ORS'92 of Merion, 
PA has been appointed Associate 
Professor of Orthopaedic Surgery. 
Join the Alumni 
for a Jefferson Update 
Plan to attend a presentation on 
The State of Thomas Jefferson University 
and Jefferson Medical College 
by Paul C. Brucker, M.D. 
President, Thomas Jefferson University 
Joseph S. Gonnella, M.D. 
Senior Vice President for Academic Affairs, Thomas Jefferson 
University, and Dean, Jefferson Medical College 
Joseph W. Sokolowski Jr. '62 
President, Jefferson Medical College Alumni Association 
Thursday, February 5, 1998 
Solis-Cohen Auditorium, Jefferson Alumni Hall 
5:00 until 6:00 
light collation immediately following 
Possible 
from Squirrels 
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ANNOUNCEMENT 
DURING the past few years Jefferson Alumni have repeatedly requested 
the publication of a bulletin to 
contain news of the College and Hospital 
and of the activities of graduates in vari-
ous portions of the world. There can be 
no doubt that many things of interest 
are happening daily, and the alumni of 
Jefferson should know of these happen-
ings. Moreover, alumni should be in 
closer touch with the College. This first 
edition of the Alumni Bulletin inaugu-
rates the policy of acquainting the 
alumni with the latest news concerning 
Jefferson. If the interest and support on 
the part of the alumni are sufficiently 
encouraging, additional bulletins will be 
issued from time to time. Expressions 
of opinion concerning the desirability 
and future character of the Bulletin 
should be addressed to the Committee. 
A Letter from the President of the Board of Trustees 
to the Corresponding Secretary of the 
Alumni Association 
AT a meeting of the Executive Com-mittee of the Alumni Association 
on August 25, 1922, the opinion 
was expressed by several members pres-
ent that there still existed an impression 
among certain of the alumni that Jeffer-
son might ultimately merge with the 
University of Pennsylvania. The Execu-
tive Committee passed a resolution that 
the Alumni Bulletin should contain a 
statement from the Board of Trustees in 
regard to the matter of merger. A letter 
was addressed to Mr. Potter, President 
of the Board of Trustees, who replied as 
follows: 
"Dear Dr. Funk: 
"Yours of the 16th inst. received. It is 
Indeed amazing that there should exist 
in the mind of any Jefferson alumnus, 
the thought that there might still be a 
merger with any friendly rival institu-
tion of medicine. 
"The administration of Jefferson Med-
ical College is unanimous that we con-
tinue as the great independent medical 
school of the United States, whose fame 
is national and international. The Jef-
ferson doctor passes more State Boards, 
and the number of living graduates of 
Jefferson is greater than that of any 
other medical college. 
"I can conceive of no change in this 
fixed policy unless unhappily the alumni 
of Jefferson should cease to continue a 
vital interest in their distinguished Alma 
Mater. 
"The Jefferson Medical College pos-
sesses famous traditions and men who 
are 'carrying on.' One of our pressing 
needs now, however, is more and more 
money to keel) abreast with friendly but 
formidable rivals. We have, in the past. 
with the spur of poverty back of us, kept 
abreast of this rivalry and God willing, 
if our large alumni, scattered all over the 
world, will add to their own interest, the 
interest of their friends, Jefferson will 
maintain her present most enviable 
position. 
"Yours faithfully, 
"WILLIAM POTTER. 
"President, Board of Trustees." 
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